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Abstract 
 
Mouse embryonic stem cells (mESCs) are derived from the inner cell mass of the 
blastocyst. When cultured in 3-D suspension in the absence of feeder cells, they 
form aggregates called embryoid bodies (EBs) that spontaneously differentiate to 
generate an outer layer of extra-embryonic endoderm with underlying basement 
membrane, an inner layer of primitive ectoderm, as well as a central proamniotic- 
like cavity. Furthermore, EBs can undergo a process that resembles gastrulation 
and can generate derivatives of the three embryonic germ layers. EBs are 
therefore very useful as model systems for investigating the early stages of 
mammalian development, and also for generating specific lineages such as 
ectoderm, mesoderm and endoderm, which can be used to investigate the 
mechanisms regulating the differentiation of specific lineages, as well as for 
regenerative medicine research. However, when used as a source for generating 
specific cell types of interest, EBs can be problematic, because only a proportion 
of cells within each EB will differentiate to become the required cell type. For this 
reason, there has been much interest in developing more efficient 2-D culture 
systems for directing the differentiation of mESCs to specific cell types. However, 
it is not clear whether cell types differentiating in EBs are equivalent to the 
corresponding cell types generated in 2-D differentiation cultures and have the 
same differentiation potential. To address this question, this study has compared 
the properties of nascent mesoderm arising in EBs with nascent mesoderm arising 
in 2-D differentiation culture. 
 
In order to do this, a mESC reporter line was created where a gene encoding the 
far-red fluorescent protein E2-Crimson (E2C) was knocked into the Rosa26 locus 
of an E14-Bra-GFP mESC line. This line enabled GFP+ nascent mesoderm cells 
to be isolated using fluorescence activated cell sorting so that the expression of 
key genes could be analysed, and then the fate of the cells could be tracked in 
ii 
living mice in vivo or following incorporation into developing organs ex vivo due 
to the fact that they constitutively express E2C. 
 
After confirming that the novel reporter E14-Bra-GFP/Rosa26-E2C mESC line 
displayed typical mESC properties and behaved similarly to unmodified mESC 
lines, the effectiveness of the E2C reporter for tracking cells in vivo and in vitro 
was assessed. Although E2C expression was stable, the fluorescence signal was 
quite weak, which meant that while it was possible to detect E2C in cells in vitro 
and on histological sections, tracking them in living mice was not feasible. For 
this reason, the study focused on comparing the gene expression profile of 
mesoderm isolated from EBs and 2-D cultures using quantitative reverse 
transcription PCR (RT-qPCR), and then their differentiation potential was 
assessed by incorporating the mesodermal cells into mouse kidney rudiments ex 
vivo. The most striking result from the RT-PCR analysis was that the mesodermal 
cells isolated from the EBs expressed >20-fold higher levels of the lateral plate 
mesoderm gene, Foxf1, compared to the mesoderm cells derived from the 2-D 
culture system. Surprisingly, neither the mesodermal cells isolated from the EBs, 
nor those isolated from the 2-D system integrated into developing nephrons within 
kidney rudiments cultured ex vivo. This result was unexpected because the kidney 
is derived from the mesodermal lineage, specifically the intermediate mesoderm, 
and so it was anticipated that nascent mesoderm cells would be able to contribute 
to the developing kidneys. However, further analysis showed that the EB-derived 
mesoderm cells differentiated into PECAM+ endothelial-like cells within the 
rudiments. It is known that the lateral plate mesoderm gives rise to the vasculature 
in the developing embryo, so the fate of the EB-derived nascent mesodermal cells 
accompanied with their high levels of Foxf1 suggested that they were likely to 
have been already specified as lateral plate mesoderm. In contrast, the 
mesodermal cells derived from the 2-D culture system showed a limited capacity 
to generate PECAM-1+ cells, and instead, appeared to integrate into the renal 
stroma. It can therefore be concluded that Bra+ mesodermal cells generated using 
iii 
different in vitro culture systems have different properties, and might already be 
specified to more differentiated mesodermal lineages, such as paraxial, 
intermediate or lateral plate mesoderm. To facilitate future progress, it would be 
useful to generate dual reporter mESC lines that enabled the expression of Bra 
and a marker of either paraxial, intermediate or lateral plate mesoderm to be 
monitored simultaneously in real-time during in vitro differentiation culture. 
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Abbreviations 
 
2-/3-D Two-/three-dimensional 
AV Adenoviral vector 
AAV Adeno-associated viral vector 
BM Basement membrane 
BMP Bone morphogenetic protein 
Bra Brachyury 
CapM Cap mesenchyme 
Cdx2 Caudal type homeobox 2 
CMV Cytomegalovirus 
DAPI 4',6-diamidino-2-phenylindole  
DEME Dulbecco's Modified Eagle's 
Medium  
DT Distal tubule 
DTA Diphtheria toxin A 
E2C E2-Crimson  
EB Embryoid body 
ECM Extra-cellular matrix 
EDTA Ethylenediaminetetraacetic acid  
ExEc Extraembryonic ectoderm 
FACS Fluorescence-activated cell sorting  
FBS Foetal bovine serum 
Fgf(r) Fibroblast growth factor(receptor) 
Fox Forkhead box  
FP Fluorescent protein 
FR Far-red 
GAPDH Glyceraldehyde 3-phosphate 
dehydrogenase 
gDNA Genomic DNA 
Gdnf Glial cell-derived neurotrophic 
factor  
GFP Green fluorescent protein 
H&E Haematoxylin and eosin  
HA Homologous arm 
HL Henle's loop 
Hox Homeobox 
HR Homologous recombination 
IM Intermediate mesoderm 
ICM Inner cell mass 
Klf4/5 Kruppel-like factor 4/5 
KSC Kidney stem cell 
Lhx1 LIM-domain homeobox 1 
LIF Leukaemia inhibitory factor 
LPM Lateral plate mesoderm 
 
 
 
LV Lentiviral vector 
mESC Mouse embryonic stem cell 
MM Metanephric mesenchyme 
NIR Near-infrared 
NRT Non-reverse transcriptase  
NTC Non-template control  
Oct4 Octamer-binding transcription  
factor 4 
Osr1 Odd-skipped-related 1  
pA Poly-A 
PBS Phosphate-buffered saline 
PECAM-1 Platelet endothelial cell  
adhesion molecule-1 
PEn Parietal endoderm 
PFA Paraformaldehyde 
PGK Phosphoglycerate kinase 
PM Paraxial mesoderm 
PNA Rhodamine-labelled peanut 
agglutinin  
PrEc Primitive ectoderm 
PrEn Primitive endoderm 
PS Primitive streak 
PT Proximal tubule 
RA Retinoic acid 
RFP Red fluorescent protein 
ROCK Rho-associated, coiled-coil 
containing protein kinase 
ROSA Reverse orientation splice acceptor  
RT-qPCR Quantitative real-time  
polymerase chain reaction  
RV Renal vesicle / retroviral vector 
SA Splice accepter 
SB S-shaped body 
SC Subcutaneous 
SD Splice donor / Standard deviation 
SDS Sodium dodecyl sulphate  
SEM Standard error of mean  
Sox2 Sry-like high-mobility group box 2 
TB Tail bud 
Tbx6 T-box protein 6 
TE Trophectoderm 
UB Ureteric bud 
VEn Visceral endoderm 
Wt1 Wilm’s tumour 1 
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Chapter 1  
 
Introduction 
                                                                   
 
Overview 
Since their derivation in the 1980s, mouse embryonic stem cells (mESCs) have 
served as invaluable tools for understanding the cellular and molecular 
mechanisms that regulate mammalian development, and for determining the 
signaling pathways required for the differentiation of specific cell lineages. For 
instance, by culturing mESCs in suspension, three-dimensional aggregates called 
embryoid bodies (EBs) are formed, which are excellent model systems that mimic 
the early stages of mouse development. As such, they have given us important 
insights into the underlying mechanisms that drive morphogenesis and embryo 
patterning (Robertson, 1987; Murray and Edgar, 2004). In addition, by culturing 
mESCs under 2-D adherent culture conditions in defined media, it has been 
possible to determine the role of specific growth factors and signaling pathways 
responsible for regulating self-renewal (Nichols and Smith, 2012), and directing 
mESC differentiation to the three embryonic germ layers (i.e., ectoderm, 
mesoderm and endoderm (Turner et al., 2014). However, what remains unclear at 
present is whether the ectodermal, mesodermal and endodermal cells that are 
formed in EBs are equivalent to those that form under 2-D culture conditions. 
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Making use of an mESC line where green fluorescent protein (GFP) is knocked 
into the brachyury locus (a gene that is expressed in nascent mesoderm), this 
thesis addresses this important question by comparing the properties of 
mesodermal cells derived from mESCs cultured as EBs with those derived under 
2-D conditions. Specifically, the expression levels of key genes were investigated, 
and the differentiation potential of the mesodermal cells were compared by 
investigating their ability to generate renal cell types in developing mouse kidney 
rudiments. To facilitate this, the gene encoding the far-red fluorescent protein, 
E2-Crimson, was knocked into the Rosa26 locus of the aforementioned Bra-GFP 
reporter mESC line to enable the fate of the cells to be monitored in vivo and in 
vitro.  
 
1.1 Development of the mouse embryo 
The mouse (Mus musculus) is a classic model organism that is commonly used in 
mammalian developmental biology. It takes 9 weeks for the mouse to develop 
from a fertilized egg into a mature adult, with the first 3 weeks being in utero, and 
the remaining 6 weeks, post-natal (Wolpert et al., 2015). According to the Theiler 
stages of mouse development, the in utero stages of development are as follows, 
where ‘E’ refers to ‘embryonic day’: fertilisation (E0-0.9), cleavage (E1.0), 
morula formation (E2.0), blastocyst formation (E3.0-E4.5), implantation 
(E5.0-E6.0), gastrulation (E6.5-E8.0), turning (E8.5), organogenesis 
(E10.0-E14.0), fetal growth and development (E14.0-E19.0/E22.0) (Theiler, 
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1989). 
 
1.1.1 Peri-implantation development of the mouse embryo  
The peri-implantation stage of mouse embryo development includes the events 
that occur between E3.0 and E6.0. After fertilisation, the embryo undergoes a 
series of cleavage divisions, forming the morula at around E2.0. At E3.0, the 
morula undergoes compaction, which involves the cells up-regulating the cell 
adhesion molecule, E-cadherin, and becoming tightly associated with each other. 
The cells that are positioned on the periphery of the embryo following compaction 
give rise to the first epithelium of the embryo, which is called the trophectoderm 
(TE), while those positioned inside the embryo contribute to the inner cell mass 
(ICM) (Fleming, 1987; Andrzej et al., 1967; Plachta et al., 2011). The TE drives 
fluid transport inside the embryo to form a fluid-filled cavity known as the 
blastocoel. At this stage the embryo is called a blastocyst. The TE cells of the 
blastocyst deposit a basement membrane (BM) at their basal surface. Following 
blastocyst formation, the cells on the surface of the ICM differentiate to form the 
primitive endoderm (PrEn), depositing a basement membrane in-between 
themselves and the remaining ICM (Nadijcka and Hillman, 1974). Following 
implantation, PrEn cells differentiate into the visceral endoderm (VEn) and 
parietal endoderm (PEn) – both giving rise to extraembryonic tissues (Gardner, 
1982). The PrEn cells in direct contact with the TE BM differentiate into the PEn, 
which migrate laterally along the TE BM to form the parietal yolk sac. The main 
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function of the PEn is to deposit a thick BM called Reichert’s membrane that is 
thought to protect the embryo from maternal immune cells (Salamat et al., 1995). 
The PrEn cells that directly overlie the ICM differentiate to VEn, which provides 
nutrients that support the growth of the early embryo and also plays an important 
role in patterning the embryo (Gardner, 1982). Shortly after implantation, the cells 
of the ICM differentiate to become the epiblast (or primitive ectoderm, PrEc) 
(Artus and Chazaud, 2014). These PrEc cells become polarized to form tall 
columnar ectodermal cells that form a pseudostratified epithelium. Shortly 
afterwards, the cells at the centre of the ICM undergo programmed cell death to 
form the proamniotic cavity (Murray and Edgar, 2000) (Figure 1.1). PrEc cells 
positioned at the future posterior part of the embryo then undergo gastrulation, 
giving rise to the three embryonic germ layers, i.e. ectoderm, mesoderm and 
endoderm.  
 
 
 
 
 
Figure 1.1 Schematic diagram of mouse embryo development from the blastocyst to 
gastrulation stages. ICM, inner cell mass; TE, trophectoderm; PrEn, primitive endoderm; 
PEn, parietal endoderm; VEn, visceral endoderm; PrEc, primitive ectoderm; ExEc, 
extraembryonic ectoderm; CEE, columnar ectodermal epithelium.  
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1.1.2 Gastrulation and germ layer differentiation  
The formation of the primitive streak (PS) marks the onset of antero-posterior axis 
determination in the developing mouse embryo (Rodriguez et al., 2005; Stern, 
2004). The epiblast cells egress through the PS to generate the nascent mesoderm 
in-between the epiblast and the overlying VEn. Within the following 12 h, the PS 
elongates anteriorly to the distal region of the egg cylinder, where the node forms 
(Arnold and Robertson, 2009). This process establishes a dorso-ventral axis 
orthogonal to the antero-posterior axis of the embryo. As the PS expands, the 
posterior PS contributes mainly to the extraembryonic mesoderm. The anterior PS 
gives rise to the axial mesoderm, paraxial mesoderm, and the outer layer of 
definitive endoderm that displaces the remaining VEn. This is followed by 
generation of the intermediate and lateral plate mesoderm from the middle PS 
(Nagy et al., 2003; Tam et al., 1987) (Figure 1.2). Detail of the germ layer 
contribution is shown in Figure 1.3 and Table 1.1. 
 
The PS comprises an early PS stage at around E6.5 and a late PS stage at E7.5 
(Tam and Behringer, 1997). It has been shown that brachyury (Bra, also known as 
T) is the key marker of the entire PS and is a pan mesodermal marker that is 
expressed until the stage of tail bud formation. Bra is one of the crucial members 
of the T-box transcription factor family (Bollag et al., 1994; Herrmann et al., 1990) 
initially identified due it its role in the mouse short-tail mutation (Herrmann and 
Kispert, 1994). 
 
 
 
6 
C
h
a
p
te
r 
1
 
Table 1.1 Germ layer and lineage formation during  
    gastrulation of the mouse embryo* 
Regions Germ Layers Dominant Lineage Constitution 
Anterior 
Primitive 
Streak 
Axial Mesoderm Notochord 
Paraxial Mesoderm Head tissues, vertebral column, bone, 
cartilage, tendon and ligament, skeletal 
muscle, dermis of dorsal skin 
Definitive Endoderm Digestive tract, respiratory tract (lung), liver, 
pancreas, prostate, thymus, thyroid 
Middle 
Primitive 
Streak 
Intermediate mesoderm Kidney, lower urinary tract,  
reproductive system 
Lateral Plate Mesoderm Limb, heart, spleen, adipose, endothelium, 
smooth muscle, circulatory system 
Posterior 
Primitive 
Streak 
Extraembryonic 
Mesoderm 
Yolk sac, amnion, allantois 
Ectoderm Definitive Ectoderm Outer layer of hair, skin, lining of nose and 
mouth, brain and nervous system 
*Gilbert, 2013 & Wolpert et al., 2015. 
 
In the mouse embryo, the onset of Bra expression is observed at E5.5 in a ring of 
distal extraembryonic ectoderm. At approximately E6.5, the expression was 
restricted to the posterior PrEc domain where PS initiates (Rivera-Pérez and 
Magnuson, 2005). Bra was subsequently found to play an important role in 
mesoderm development (Herrmann and Kispert, 1994; Takada et al., 1994). 
During mesoderm formation, Bra expression is found in the posterior epiblast/PS, 
node/notochord, allantois and tail bud (Kispert and Herrmann, 1994; Kispert et al., 
1995; Papaioannou, 2014; Concepcion and Papaioannou, 2014; Wilkinson et al., 
1990; Showell et al., 2004; King et al., 1998; Conlon et al., 1995). Bra deficiency 
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Figure 1.2 Schematic demonstration of mesoderm patterning during the mouse 
embryo development. A, dorsal view of the gastrulated embryo at E7.0, showing 
specification of ectoderm and endoderm and formation of the primitive streak (PS) and the 
derived paraxial, lateral plate and intermediate mesoderm (PM, LPM, IM) along the 
anterior-posterior axis (A-P); B, dorsal view of the E8.5 embryo, showing patterning of PM, 
LPM, IM along the  anterior-posterior axis; C, cross section of E8.5 embryo at the 
posterior region, showing the specification of PM, LPM, IM along the dorsal-ventral (D-V) 
axis. 
 
results in a lack of migrating mesodermal cells and a failure of PS, notochord and 
tail bud formation (Herrmann and Kispert, 1994). Moreover, notochord elongation 
and tail bud differentiation is dependent upon sufficient levels of Bra along the 
rostro-caudal axis (Kispert and Herrmann, 1994). Genetic and functional studies 
have revealed that Bra functions endogenously as a transcription activator for 
specific mesoderm genes by binding to a palindromic target sequence through a 
conserved region of T-domain. Bra downstream targets such as eFGF (embryonic  
fibroblast growth factor), Bix1/4 and XWnt1 have been isolated in Xenopus 
 
 
 
8 
C
h
a
p
te
r 
1
 
 
 
Figure 1.3 Schematic fate map of germ layer and lineage relationship of mouse 
embryo development. ICM, inner cell mass. 
 
experiments (Kispert and Herrmann, 1993; Kispert et al., 1995; Casey et al., 1998; 
Kusch, 2002; Showell et al., 2004). 
 
Promoter analysis has shown that Bra is a target of the Wnt/β-catenin signalling 
pathway that requires Wnt3 and Wnt3a (Arnold et al., 2000; Liu et al., 1999; 
Yamaguchi et al., 1999). At the egg cylinder stage, Wnt3 expression is detected at 
E5.5 in a small region of posterior VEn overlying the epiblast at the 
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epiblast/extraembryonic ectoderm boundary and is evident in both VEn and 
posterior epiblast by E6.0, preceding the onset of Bra expression (Rivera-Pérez 
and Magnuson, 2005). It has been suggested that Wnt3 promotes localised 
generation of activated β-catenin in the cells fated to give rise to mesoderm 
(Takada et al., 1994; Rivera-Pérez and Magnuson, 2005; Liu et al., 1999). Wnt3a 
also plays an essential role in PS mesoderm formation and movement. Loss of 
Wnt3a activity results in abnormal PS and a deficiency of trunk paraxial 
mesoderm (Takada et al., 1994; Yoshikawa et al., 1997). 
 
The bone morphogenetic protein (BMP) and FGF signalling pathways carry 
additional functions during PS mesoderm formation and migration. Mutation of 
Bmp4 leads to a deficiency in ventral mesoderm differentiation (Winnier et al., 
1995). It is proposed that BMP signalling induces the mesoderm to pattern along 
the dorsal-ventral axis in a dose-dependent manner, in which high levels stimulate 
lateral plate mesoderm fate while low levels promote intermediate mesoderm fate. 
Paraxial mesoderm fate is, however, repressed in the presence of BMP signals 
(James and Schultheiss, 2005). Moreover, the BMP signalling is regulated by its 
antagonists such as Chordin and Noggin (Canalis et al., 2003). Inhibition of 
BMP4 promotes neural differentiation in mESC cultures (Gratsch and O'Shea, 
2002). In mouse fibroblast growth factor receptor 1(FGFR1) mutants, abnormal 
accumulation of ingressed mesodermal cells has been observed in the PS where 
Bra expression is attenuated but E-cadherin expression is up-regulated. It is 
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evident that perturbing E-cadherin expression de-represses Wnt3a expression and 
rescues Bra expression, indicating a molecular link between FGF and Wnt 
signalling (Yamaguchi et al., 1994; Ciruna and Rossant, 2001). 
 
Apart from their functions in the PS development, Bra and Wnt proteins 
orchestrate as an autologous regulatory loop to create and maintain a posterior 
mesoderm progenitor niche during somitogenesis (Martin and Kimelman, 2010). 
Retinoic acid (RA) signalling has been shown to repress the expression of 
Zebrafish Bra ortholog ntl via the RA receptor (RAR) in the somite progenitors, 
leading to a disruption of posterior mesoderm specification. Conversely, Ntl 
prevents the effects of RA by directly activating expression of the RA-degrading 
enzyme gene, cyp26a1 (Martin and Kimelman, 2010). 
 
1.2 In vitro models of mouse development  
The small size and inaccessibility of the peri-implantation mouse embryo makes it 
difficult to study. However, shortly following the isolation of embryonic stem 
cells (ESCs) from mouse blastocysts in the 1980s (Evans & Kaufman, 1981; 
Martin, 1981) it was found that by culturing ESCs in suspension, aggregates are 
formed that could recapitulate some of the key events of peri-implantation mouse 
development. For this reason, these aggregates were termed ‘embryoid bodies’ 
and provide an excellent model system for studying the early events of mouse 
development (Robertson, 1987). 
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1.2.1 Mouse embryonic stem cells (mESCs) 
mESCs were first successfully derived from the ICM of either diapause 
blastocysts of mouse strain 129/SvE (Evans and Kaufman, 1981) or early 
blastocysts of mouse (ICR×SWR/J) embryos (Martin, 1981; Martin and Evans, 
1981; Nichols and Smith, 2012; Hogan et al., 1994; Kawase et al., 1994; Suzuki 
et al., 1999). When maintained in vitro on a layer of fibroblast feeder cells in the 
presence of foetal bovine serum, mESCs can be maintained in a self-renewing and 
pluripotent state, thus resembling the cells within the ICM of the mouse blastocyst 
(Evans and Kaufman, 1981; Martin, 1981). More recently, more defined 
conditions for propagating mESCs have been developed that typically comprise 
feeder-free and serum-free culture in the presence of leukaemia inhibitory factor 
(LIF) and inhibitors of specific signalling pathways (e.g., the mitogen-activated 
protein kinase (MEK) inhibitor, PD032590, and the glycogen synthase kinase 3 
(GSK-3) inhibitor, CH99021 (Wray et al., 2010; Dunn et al., 2014). It is known 
that LIF activates the signal transducer and activator of transcription 3 (Stat3), 
which promotes self-renewal by inducing expression of Klf4 (Nichols and Smith, 
2012). However, LIF can also activate MAPK/Erk (mitogen-activated protein 
kinase/extracellular signal-regulated kinase) pathways that can drive mESC 
differentiation. This is the reason why the inclusion of a MEK inhibitor can 
promote mESC self-renewal (Niwa et al., 1998; Matsuda et al., 1999; Guo et al., 
2009; Burdon et al., Batlle-Morera et al., 2008).  
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Several master regulatory transcription factors expressed in the ICM of the 
blastocyst are essential for maintaining mESC self-renewal and pluripotency, of 
which octamer-binding transcription factor 4 (Oct4, also known as POU5F1) and 
homeoprotein Nanog are essential for maintaining stemness. A key role of Oct4 in 
the ICM is to supresses caudal type homeobox 2 (Cdx2), thus ensuring that the 
expression of this transcription factors is restricted to the TE (Arnold and 
Robertson, 2009). Nanog is initially expressed at a low level in some of the 
morula cells but reaches a higher expression level in the blastocyst and is essential 
for maintaining the cells in an undifferentiated state. Together with another 
epiblast transcriptional factor Sry-like high-mobility group box 2 (Sox2), Oct4 
induces the expression of Nanog to regulate mESC pluripotency (Basilico et al., 
1997; Mitsui et al., 2003). Other transcription factors, including Kruppel-like 
factor (Klf) 4 (Li et al., 2005; Hall et al., 2009) and Klf5 (Ema et al., 2008) 
interact with the core regulatory network, and their role in maintaining stemness is 
indispensable (Luo et al., 1997; Davenport et al., 2003; Narducci et al., 2002; 
Jiang et al., 2008).  
 
Under proper culture conditions and without stemness promoting factors, the 
mESCs undergo spontaneous differentiation and give rise to the derivatives of all 
three germ layers, i.e. ectoderm, mesoderm and endoderm (Keller, 2005; Smith, 
2001). The in vitro differentiation of mESCs offers approaches to understand cell 
fate decision and could also have uses in regenerative medicine by generating 
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important cell types that could be used to treat degenerative diseases. General 
protocols to promote in vitro mESC differentiation include: i) suspension culture 
to promote embryoid body (EB) formation, ii) use of defined supplements such as 
extra-cellular matrix (ECM), growth factors and signalling molecules within 
two-dimensional (2-D) or three-dimensional (3-D) culture, iii) enhancement of 
specific gene expression by genetic manipulation of mESCs and iv) use of 
supportive stromal cells in co-culture conditions (Kurosawa, 2007). Among such, 
the use of the EB system is particularly advantageous because of the similarities 
between the development of EBs and the peri-implantation mouse embryo 
(Robertson, 1987). 
 
1.2.2 EB model system 
When cultured in suspension in vitro in the absence of feeder cells and LIF, 
mESCs spontaneously form spheroid multicellular aggregates called embryoid 
bodies (EBs) (Wobus et al., 1984; Doetschman et al., 1985). According to their 
development stages, EBs are categorised as simple (2–4 days post plating), 
cavitating (4–5 days post plating), and larger cavitated (over 8 days post plating) 
EBs (Kurosawa, 2007; Abe et al., 1996). The development of EBs mimics 
peri-implantation mouse embryo development (Wobus et al., 1984; Doetschman 
et al., 1985). A typical EB has an outer layer of PrE, an inner layer of PrEc, a 
basement membrane separating them, as well as a central cavity that resembles 
the proamniotic cavity (Figure 1.4) (Shen and Leder, 1992). The PrEc 
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differentiates to generate derivatives of definitive ectoderm, endoderm and 
mesoderm (Wobus et al., 1984; Doetschman et al., 1985; Keller et al., 1993). 
Specification of mesoderm was observed in EBs generated from R1 mESCs, and 
also identified by the expression of Bra in EBs formed by D3 and E14 mESC 
lines (Park et al., 2004; Doetschman et al., 1985; Fehling et al., 2003). Similar to 
the effect in vivo, BMP4 was found to promote mesodermal formation in the EBs 
(Park et al., 2004). However, once the EBs have differentiated towards 
mesoderm, the presence of high concentrations of BMPs could suppress the 
nascent mesoderm from giving rise to renal lineages in EBs (Bruce et al., 2007).  
 
Several approaches have been developed to generate EBs within the laboratory 
(Figure 1.5). Mouse EBs cultivated in suspension using bacterial-grade petri 
dishes have been successfully induced towards neurogenesis (Plachta et al., 2004), 
cardiogenesis (Klug et al., 1996), vasculogenesis (Risau et al., 1988; Feraudet et 
al., 2001) and chondrogenesis (Hwang et al., 2006). Because individually 
distributed mESCs encounter each other in a spontaneous and random manner, the 
resulting EBs are heterogeneous in morphology, hence forming an irreproducible 
mixture of derivative populations (Wartenberg et al., 1998). As a modification, 
methylcellulose culture introduces semi-solid methylcellulose media into the 
bacterial-grade petri dish culture and thus provides good reproducibility, resulting 
in a population of EBs that is more homogeneous. Hanging drop culture is another 
frequently-used method to produce EBs. By plating a small volume of cell 
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suspension onto the lid of petri dishes, it is possible to achieve good control of EB 
size and number so that they are homogeneous and reproducible. The drawbacks  
 
 
 
 
Figure 1.4 Schematic Illustration comparing the development between the early 
mouse embryo (A, top panel) and EBs (A, bottom panel, and B). Day 5 mESC-derived 
EBs comprise of an outer layer of primitive endoderm (PrEn) and an inner layer of 
columnar primitive ectoderm (PrEc) surrounding a proamniotic-like cavity, Cav) separated 
from each other by a basement membrane (BM). The PrEc can give rise to the definitive 
ectoderm, endoderm and mesoderm, mimicking early mouse embryo development. ICM, 
inner cell mass; TE, trophectoderm; PEn, parietal endoderm; VEn, visceral endoderm; 
ExEc, extraembryonic ectoderm; CEE, columnar ectodermal epithelium. 
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of the hanging drop method are the limited number of EBs that can be generated, 
as well as the time-consuming preparation process, which increases the possibility 
of introducing microbial contamination (Höpfl et al., 2004). To address this, 
low-adherence culture dishes have been designed. Suspension culture using 
round-bottom 96-well plates that are treated with specific cell adhesion repellents 
show efficient formation of uniform EBs with homogeneous size and shape 
(Konno et al., 2005; Shinji et al., 1988; Suslov et al., 2002; Koike et al., 2005). 
This method facilitates monitoring of the differentiation of EBs with defined 
seeding densities (Kurosawa, 2007). 
 
 
 
 
Figure 1.5 Schematics of four types of laboratory approaches to produce EBs from 
mESCs. Under standard culture conditions and without stemness promoting factors, the 
mESCs spontaneously differentiate into the germ layer derivatives of ectoderm, 
mesoderm and endoderm.  
 
1.2.3 2-D induction system 
EBs are a very good in vitro differentiation model of early embryo development. 
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However, as a source of specific types of differentiated cells, such as mesoderm, 
EBs can be problematic. This is because the heterogeneous nature of the EBs 
means that the extent of differentiation towards any specific cell type can vary 
considerably between EBs. The complex 3-D structure also hinders the 
visualisation of the differentiation process at an individual cell level. For this 
reason, various 2D differentiation protocols have been developed to direct 
differentiation to specific cell-types more efficiently. Typically, 2D culture 
systems include defined, serum-free growth media. This is because serum 
contains unknown factors that may cause variations in cell differentiation, and 
also makes it difficult to investigate the role of specific growth factors in driving 
differentiation (Turksen, 2002). In addition, feeder cells are usually eliminated as 
they may influence the outcome of differentiation (Pollard and Walker, 1997). In 
addition to culture media, extra cellular matrix (ECM) molecules that comprise 
the ESC culture substrate also regulate self-renewal and differentiation. Coating 
tissue culture plates with substrates including gelatin, laminin, fibronectin, or 
collagen type-IV may improve mESC adherence and survival, and in such ways, 
several studies have demonstrated in vitro derivation of mono-layer mESCs into 
lineages of neural progenitors, endothelial cells, paraxial mesoderm, intermediate 
mesoderm and renal precursors using chemically defined media (Ying and Smith, 
2003; Blancas et al., 2013; Blancas et al., 2011; Sakurai et al., 2009; Oeda et al., 
2013; Furue et al., 2005; Bruce et al., 2007). 
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Recently, Tuner et al showed that Activin/Nodal and Wnt signalling pathways 
promote mesoderm formation in monolayer mESC culture, and the mesodermal 
cells differentiated from mESCs displayed Bra expression, similarly to the nascent 
mesoderm that develops in the primitive streak of developing mouse embryos and 
of ‘gastrulating’ EBs. By using a combination of Activin A (activates the 
Activin/Nodal pathway) and Chiron (activates the Wnt3a pathway), this group 
developed a highly efficient strategy for inducing E14 mESCs to differentiate into 
nascent mesoderm. After 2-day culture in neural differentiation medium and a 
further 2-day culture in medium supplemented with Activin A and Chiron, robust 
Bra expression was observed in over 90% in the population (personal 
communication) (Turner et al., 2014a and 2014b).  
 
However, although mesoderm differentiation occurred within both the 3-D and 
2-D mESC culture systems, it is not clear whether the differentiated cells (e.g. 
mesodermal cells) that are generated by the 2-D protocols are equivalent to those 
that form in the EBs and this still needs to be elucidated.  
 
1.3 In vitro and in vivo fluorescence-based cell tracking technology 
During the past two decades, considerable advances have been made in the field 
of fluorescent probe-based imaging technology, especially in terms of the range of 
specific fluorescent probes and commercial instrumentation.   
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1.3.1 Non-genetic cell labelling 
A variety of different non-endogenously-expressed fluorescent probes have been 
produced for cell labelling. According to the cell compartment that is labelled, 
they are classified as membrane, cytoplasmic, endocytic or nuclear labels. The 
membrane labels include a range of lipophilic, carbocyanine fluorescent 
chemicals, which bind to the lipid bilayer of cell membranes with their aliphatic 
fraction. Commonly used examples of lipophilic membrane labels include PKH 
and DiI (Lo Celso et al., 2008; Horan and Slezak, 1989; Parish, 1999; Hendrikx et 
al., 1996; Ashley et al., 1993; Haldi et al., 2006; Yusuf et al., 2009; Sipkins et al., 
2005; Lane et al., 2011; Sanchez-Aguilera et al., 2011; Wagner et al., 2010; He et 
al., 2012). The cytoplasmic, endocytic and nuclear labelling probes include 
amine-reactive probes (e.g. Carboxyfluorescein succinimidyl ester, CFSE, and 
carboxyfluorescein diacetate succinimidyl ester, CFDA-SE) (Lyons and Parish, 
1994), nanocrystals (e.g. quantum dots, QDs), and bisbenzimides (e.g. Hoechst 
33342), respectively. Because of the ability to bind to cytosolic components or 
DNA and thus to provide uniform staining, they have been applied to study 
mammalian cells (Parish, 1999; Lyons and Parish, 1994; Kohler et al., 2009; 
Lewandowski et al., 2010; Lin et al., 2007; Muller-Borer et al., 2007; Rosen et al., 
2007; Link and El-Sayed, 2000; Mohamed et al., 2000; Mempel et al., 2006). 
These non-genetic probes are available in multiple colours and have the advantage 
of being able to label cells rapidly and efficiently. However, membrane binding 
dyes were found to readily transfer to host cells, thus giving false-positive staining 
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(Li et al., 2013; Serbedzija et al., 1989). Moreover, the rapid dilution of the 
fluorescent signal upon cell division has limited their application, particularly in 
longer-term cell tracking (Lyons and Parish, 1994; Parish, 1999; Muller-Borer et 
al., 2007; Zhu et al., 2014). 
 
1.3.2 Genetic cell labelling 
Fluorescent reporter genes provide stable expression of the fluorescent signal in 
the cells in which they are expressed, hence being ideal for long-term cell tracking. 
This can be obtained through genomic manipulation by using viral transduction or 
plasmid transfection to establish labelled transgenic cell lines.  
 
1.3.2.1  Virus-mediated transgenesis 
Viral transduction has been created as a molecular protocol by which cloned 
genetic materials can be transferred and inserted into cells of interest by using 
viruses or viral vectors as tools (Hamer and Leder, 1979). Three main types of 
viral vector have been designed: adenoviral or adeno-associated viral vectors 
(AVs or AAVs), retroviral vectors (RVs), and lentiviral vectors (LVs) (Kay et al., 
2001). AVs or AAVs are episomal DNA-based vectors that can infect both 
dividing and non-dividing cells; however, they do not replicate nor integrate into 
the recipient genome (Trono, 2000; Adamson et al., 2011; Hansen1 et al., 2000; 
Wickham et al., 1993). RVs are RNA-based vectors which replicate by reverse 
transcriptase. They are the first type of viral vector used to establish transgenic 
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mESC lines (Robertson et al., 1986). A disadvantage, however, is that they can 
only be used to transduce proliferating cells (Yamagata et al., 2012). LVs are a 
sub-class of RVs that are able to infect both dividing and non-dividing cells 
(Naldini et al., 1996; Roe et al., 1993). The transduction efficiency of these 
vectors is dependent on the species and cell-type (Smith-Arica et al., 2003; Asano 
et al., 2002; Lois et al., 2002; Pfeifer et al., 2002; Cheery et al., 2000). The site 
and copy number of the viral-based integration is unpredictable. Of note, there is a 
high prevalence of transcriptional silencing of the transgene in vitro and in vivo 
which may be due to DNA methylation (Jaenisch et al., 1985; Laker et al., 1998; 
Yoder et al., 1997; Jähner and Jaenisch, 1985). 
 
1.3.2.2   Gene targeting and knock-in of fluorescent reporters 
Gene targeting is achieved by homologous recombination (HR), which occurs 
between two co-introduced DNA molecules upon the exchange of their genetic 
sequences (Folger et al., 1982). Gene targeting refers to the homologous 
recombination between the endogenous chromosome and exogenous DNA 
sequences (Capecchi, 1989a). Following on from the discovery that mESCs could 
be introduced into blastocysts to generate chimeras, and the development of 
transgenic mESC lines, the first genetically manipulated mouse was soon 
generated (Bradley et al., 1984; Thomas and Capecchi, 1987, 1990; McMahon 
and Bradley, 1990). This breakthrough paved the way for the widespread 
generation of genetically modified mouse strains using mESCs. To achieve this, 
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targeting vectors are constructed. Four main types of vectors, replacement, 
knock-in, conditional and insertion, are designed to suit specific approaches. 
Amongst them, the knock-in vectors serve as exogenous gene carriers to 
incorporate the reporter genes into the chromosomal locus of interest, 
subsequently leading to the disruption of the targeted locus with expression of the 
transgene (Adams and van der Weyden, 2008).  
 
For transgenic cell lineages and mouse lines, fluorescent reporter genes are 
commonly used. The wild-type GFP is a protein of 238 amino acids derived from 
the jellyfish Aequorea victoria that has limited toxicity when expressed in cells 
(Johnson et al., 1962; Shimomura et al., 1962). However, native GFP has some 
drawbacks, including a tendency of the protein to undergo dimerisation, dual 
excitation maxima (i.e., excited by both blue and ultraviolet light), poor 
photostability and poor folding at 37°C. To overcome these, a wide variety of GFP 
variants with enhanced properties have been designed for use. Engineered GFP 
mutants, such as enhanced GFP (eGFP) (Yang et al., 1996; Cormack et al., 1996), 
AcGFP1 (Chen et al., 2002; Gurskaya et al., 2003), and ZsGreen1 (Matz et al., 
1999; Haas et al., 1996), provide brighter emission of green fluorescence that is 
detectable by common filters with single excitation maxima and a reduced 
frequency of oligomerisation. Other novel GFP derivatives, for instance, blue, 
cyan, yellow and orange fluorescent proteins have now been developed, covering 
the entire visible spectrum (Alford et al., 2013).  
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Red fluorescent proteins (RFPs) have emission maxima that span from the 
yellow-orange (575 nm–610 nm wavelength) to far-red (710 nm–850 nm 
wavelength) regions of the spectrum, thereby advancing the fluorescence protein 
spectral range to include longer wavelengths (Alford et al., 2013). Lukyanov and 
colleagues identified naturally-occurring reef coral RFPs, including amFP486 
(Matz et al., 1999), eqFP578 (Merzlyak et al., 2007), and DsRed (or drFP583) 
(Matz et al., 1999). 
 
In order to deliver the transgenes, vectors are usually linearised and electroporated 
into the recipient cells, which involves physical transfer in an electric field that 
may cause cell damage (Neumann et al., 1982). This accounts for the relatively 
low efficiency of homologous recombination gene targeting. Another reason is the 
limited capacity of the cell enzymatic machinery that leads to low frequency of 
homologous recombination but high frequency of random recombination 
(Mansour et al., 1988; Capecchi, 1989b; Vasquez et al., 2001). Increasing the 
length of homologous arms enhances the frequency of homologous recombination 
(Thomas and Capecchi, 1987; Deng and Capecchi, 1992). To efficiently select the 
correctly integrated recombinants, the selection markers are crucial. A neomycin 
(neo) cassette is the most commonly used. An additional negative selection gene, 
such as the diphtheria toxin A-fragment (DT-A) gene, can significantly increase 
the yield of correct targets (Yagi et al., 1993; Yagi et al., 1990). The resultant 
recombinants bare genetically-expressed fluorescent proteins that produce 
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constant fluorescent signals and they are thus suitable for long-term cell tracking 
studies.  
 
Recently, Fehling et al generated an E14-Bra-GFP mESC line to investigate 
mesodermal differentiation in vitro. In this line, an eGFP mini gene cassette was 
targeted into the Bra locus, replacing approximately two-thirds of exon 1 of Bra. 
GFP expression was under the control of the Bra promoter, which means that 
cells that undergo mesoderm differentiation are marked by GFP fluorescence 
(Fehling et al., 2003). Using this cell line, Fehling et al developed an EB culture 
protocol that yielded a high proportion of GFP
+
 cells. The GFP
+ 
cells isolated in 
vitro have shown the ability to generate mesodermal derivatives including the 
haematopoietic and cardiac lineages, as well as neuromesodermal progenitors 
(Fehling et al., 2003; Zhang et al., 2014; Org et al., 2015; Tsakiridis and Wilson, 
2015), although there is a lack of evidence that the expression pattern of GFP can 
accurately recapitulate that of endogenous Bra expression in the mouse embryo.   
 
The latest breakthrough of generating transgenic lines is achieved by the clustered 
regularly interspaced short palindromic repeats (CRISPR)-based technologies. 
CRISPRs were first identified in Escherichia coli (Ishino et al., 1987). CRISPR 
loci and the co-localised endonuclease CRISPR-associated proteins (Cas) have 
been widely described as essential components of the adaptive immune system in 
bacteria and archaea (Doudna and Charpentier, 2014). In this system, CRISPR 
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RNAs (crRNAs) direct Cas to bind the target sequence (called spacer) of the 
invading DNA via complementary base pairing and cleave the DNA, generating 
double strand breaks (Wiedenheft et al., 2009). The most common approach uses 
CRISPR-Cas9 protein and single guide RNA (sgRNA) or duplex of 
crRNA:trans-activating crRNA (tracrRNA) to direct DNA cleavage. A protospacer 
adjacent motif (PAM) at the 3’ end of the spacer is also required to ensure the 
cleavage specificity (Doudna and Charpentier, 2014). DNA breaks can be repaired 
by non-homologous end joining, which leads to stochastic insertions and/or 
deletions at the target site, or homology-directed recombination, which results in 
introduction of desired sequence in the presence of donor DNA templates (Komor 
et al., 2017). This has made it possible to apply CRISPR-Cas9 technology to 
target genome modification in human and mouse cells (Cong et al., 2013; Jinek et 
al., 2013; Mali et al., 2013). Moreover, recent studies have reported the generation 
of gene-targeted mouse models via CRISPR-Cas9 injection into the zygote, 
indicating a convenient and time-saving approach without the need for genetically 
modifying mESCs (Yang et al., 2014; Wang et al., 2013). Of note, in this way, the 
efficiencies distinctly varied, with only 10‒20% efficiency regarding the large 
fragment insertion (e.g. gene reporter). This, together with other limitations 
including high off-target mutation rate in human cells, suggests future efforts 
should focus on enhancing the outcomes of homology-directed repair (Ran et al., 
2015; Kuscu et al., 2014; Fu et al., 2013; Hsu et al, 2013).   
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1.3.3 In vitro and in vivo optical imaging technology 
1.3.3.1   In vitro optical imaging 
Since the invention of the first fluorescence microscope, there has been 
continuous development in the field of optical imaging (Rusk, 2009). With 
advances in a broad spectrum of fluorescent probes and computer technology, 
highly specialised microscopes have made in vitro imaging an invaluable 
experimental methodology. For instance, the Cell-IQ
® 
system (Chip-Man 
Technologies, Finland) provides an integrated instrument combining an inverted 
phase-contrast/fluorescent microscope and a simplified tissue culture incubator, 
thus enabling automated real-time monitoring of proliferation, migration, 
morphology and fluorescence in living cells. Studies have been performed to 
monitor the behaviour of human mesenchymal stems and human embryonic stem 
cell differentiation under adapted in vitro conditions (Walter et al., 2010; Hicks et 
al., 2009; Nat et al., 2007; Narkilahti et al., 2007).  
 
1.3.3.2   In vivo optical imaging 
In vivo optical imaging enables the study of living organisms by monitoring and 
characterising physical and biological processes within specific cells or tissues of 
interest. Fluorescence-based labelling serves as an ideal tool for in vivo imaging in 
animals. However, due to the photon absorption by tissue haemoglobin (<650 nm 
wavelength region) and water (>900 nm wavelength region), the majority of the 
visible fluorescence (e.g. GFP green emitted light) is absorbed within 500 µm of 
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the surface tissue of the recipient animal. To circumvent this, an optical window 
of approximately 650 nm–900 nm of the near infra-red wavelength region of the 
spectrum is favourable, which allows maximum depth of fluorescence penetration 
(Weissleder, 2001). In addition, cell nuclei and mitochondria cause light scattering 
within the optical window (Wang and Wu, 2007), whereas the intensity can be 
reduced by using longer wavelengths (Shcherbo et al., 2007). This requires 
fluorescent probes which have the emission spectra within the far-red (FR) region 
(710 nm–850 nm wavelength, which is part of the near-infrared spectrum). From 
this perspective, a series of DsRed- or eqFP578-derived FR fluorescent proteins 
(FPs) have been developed, comprising i) monomers mPlum (Wang et al., 2004), 
mRasperry (Wang et al., 2004), mKate (Shcherbo et al., 2007), mKate2 (Shcherbo 
et al., 2009), mRFP (Campell et al., 2002), and pseudomonomer tdKatushka 
(Shcherbo et al., 2009), and ii) oligomers DsRed (Matz et al., 1999), Katushka 
(Shcherbo et al., 2007), RFP637 (Kredel et al., 2008), RFP639 (Kredel et al., 
2008), and E2-Crimson (Strack et al., 2009).  
 
Wild-type DsRed is a 28-kDa natural fluorescent tetramer isolated from 
Discosoma sp. (Campell et al., 2002). It has excitation and emission peaks at 
approximately 560 nm and 585 nm, respectively (Strack et al., 2009). In 
comparison to most GFP derivatives, it is insensitive to pH and resistant to 
photobleaching but is prone to form precipitated aggregates that are cytotoxic 
(Baird et al., 2000). A series of modified DsRed variants are commercially 
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available with higher solubility, including monomeric mutants such as 
DsRed-monomer (Campell et al., 2002), mCherry, mStrawberry (Campell et al., 
2002; Shaner et al., 2004; Wang et al., 2004), mPlum and mRaspberry (Shaner et 
al., 2004; Wang et al., 2004), dimeric mutants such as tdTomato (Campell et al., 
2002; Shaner et al., 2004; Wang et al., 2004), as well as tetrameric mutants such 
as DsRed-Express (Bevis and Glick, 2002 ), DsRed-Express2 (Strack et al., 2008), 
DsRed2 (Bell et al., 2007; Yanushevich et al., 2002; Matz et al., 1999) and 
E2-Crimson (Strack et al., 2009) (Table 1.2).  
 
E2-Crimson is a novel tetramer derived from DsRed-Express2 and retains 
DsRed-Express2’s advantages including fast maturation, high solubility, high 
photostability and low cytotoxicity. Furthermore, it has the excitation and 
emission maxima of 611 nm and 646 nm, respectively. This means that it can be 
excited efficiently by standard far-red lasers of routinely-used optical 
instrumentation. Hence, it is suitable for multi-colour in vivo imaging for cell 
tracking (Strack et al., 2009)  
 
To visualise the fluorescent signal, instruments such as the In Vivo Imaging 
System
® 
(IVIS, PerkinElmer, UK) have been employed, which possess detectors 
for a wide optical spectrum between the blue and near infrared that facilitate 
intravital monitoring of cells expressing fluorescent reporters in small living 
animals (Chu et al., 2014).  
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Table 1.2 Properties of commercially available DsRed-derived  
red and far-red fluorescent proteins 
 
Fluorescent 
Proteins 
Quaternary 
Structure 
Excitation/ 
Emission  
Maxima  
(nm) 
Brightness 
Relative to 
eGFP  
(%)† 
Maturation 
Half-time 
at 37°C 
(min) 
References 
DsRed-Express Tetramer 554/586 92 36 
a, b 
DsRed-Express2 Tetramer 554/591 93 42 
b 
tdTomato Dimer 554/581 591 60 
c 
DsRed-Monomer Monomer 557/592 24 <60 
d 
DsRed2 Tetramer 563/582 150 390 
     a, e-g 
mCherry Monomer 587/610 98 15 
c-d 
mStrawberry Monomer 574/596 162 55 
c-d 
mPlum Monomer 590/649 25 100 
c,h 
mRaspberry Monomer 598/625 80 55 
c,h 
E2-Crimson Tetramer 611/646 180 26 
i 
† http://www.clontech.com d Campbell et al., 2002 g Matz et al., 1999 
a Bevis and Glick, 2002 e Bell et al., 2007 h Wang, 2004 
b Strack et al., 2008  f Yanushevich et al., 2002 i Strack et al., 2009 
c Shaner et al., 2004      
      
 
1.4 Aims 
The differentiation of Bra
+
 mesoderm occurs spontaneously in developing EBs, 
and this process appears to mimic the differentiation of nascent mesoderm in the 
gastrulating mouse embryo. For instance, in both the embryo and in 
mESC-derived EBs, the nascent mesoderm appears to arise from a primitive 
ectodermal epithelium. In contrast, when mESCs are directed to differentiate to 
Bra
+
 mesoderm under 2-D culture conditions, the mesodermal cells are not 
derived from primitive ectodermal epithelial cells, and instead, appear to 
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differentiate directly from undifferentiated mESCs. This raises the question of 
whether the mesoderm arising in the EBs is equivalent to the mesoderm that is 
generated in 2-D culture systems. 
 
The main focus of this work was to compare the two mesoderm populations 
derived from the 3-D (i.e., EBs) and 2-D mESC culture systems and examine 
whether they are equivalent to each other. This was achieved by comparing their 
gene expression profile using quantitative RT-PCR and investigating their 
differentiation potential by incorporating the mesodermal cells into developing 
mouse kidney rudiments (the kidneys being derived from the mesodermal lineage). 
The specific objectives were as follows:  
1. To generate a novel E2-Crimson (E2C)-expressing mESC reporter line by 
knocking the E2C gene into the Rosa26 locus of the E14-Bra-GFP mESC 
line. This new line would allow the fate of the GFP
+
 mesodermal cells to 
be followed in the developing kidneys due to the fact that they would 
constitutively express E2C;  
2. To evaluate the effectiveness of the E2C fluorescence reporter for tracking 
the newly-generated Bra-GFP/Rosa26-E2C mESCs in living mice; 
3. To characterise the mesoderm derived from the Bra-GFP/Rosa26-E2C 
reporter mESCs cultured under the 3-D and 2-D conditions by determining 
the expression levels of key genes using quantitative RT-PCR; 
4. To evaluate the nephrogenic potential of the mesoderm derived from the 
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Bra-GFP/Rosa26-E2C reporter mESCs cultured under the 3-D and 2-D 
conditions. This was achieved by assessing the differentiation potential of 
the E2C
+ 
mesodermal cells following their incorporation into developing 
mouse kidney rudiments ex vivo.    
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Chapter 2 
 
Materials and Methods 
                                                                   
 
2.1 Cell lines and media 
The cell lines used in this project are shown in Table 2.1. Details of media are 
listed in Table 2.6. 
 
Table 2.1 List of cell lines 
Cell Lines Sources 
SNL76/7 (STO) ATCC, SCRC-1049 
E14TG2a (mESC) ATCC, CRL-1821 
E14-Bra-GFP (mESC) G. Lacaud, Manchester 
GFP-KSCs 
(mouse neonatal 
kidney-derived stem cells) 
 
tdTomato-transduced 
E14-Bra-GFP mESCs 
 
In-house 
 
 
2.2 Thawing and freezing cells 
For thawing cells, cryovials were removed from liquid nitrogen and placed in 
37oC water bath. Once defrosted, cell suspension was transferred to 15 mL conical 
tubes containing 10 mL medium and centrifuged at 200×g for 2 min. Supernatants 
were aspirated and cell pellets resuspended in fresh medium and transferred to 
tissue culture plates that had been pre-coated with gelatin (1g/L gelatin, Sigma, 
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G1890). 
 
For freezing cells, medium was aspirated and cells were washed with 1× 
phosphate-buffered saline (PBS) (without Ca2+ and Mg2+) (Sigma, D8537), 
trypsinised using 1×trypsin/EDTA (Sigma, T4174). The trypsin was neutralized 
using complete medium. Cell pellets were collected by centrifugation at 200×g for 
2 min and resuspended in Recovery™ Cell Culture Freezing Medium (Thermo 
Fisher Scientific, 12648). Cells were counted and 1 mL of cell suspension 
containing approximately 106 cells was transferred into each cryovial. The 
cryovials were stored in freezing containers filled with 2-propanol at -80oC 
overnight, and then transferred to liquid nitrogen. 
 
2.3 Preparation of mitomycin-C-inactivated STO feeder cells  
24 h prior to the inactivation, the STO culture medium was replaced with 10 mL 
fresh medium. For the inactivation, half of the medium was removed and 5 mL 
medium was retained. Mitomycin-C (Sigma, M4287) was added to give a final 
concentration of 20 µg/mL. The dishes were incubated at 37oC in a humidified 
incubator with 5% CO2 for 2 h. Cells were washed three times with 1×PBS 
(without Ca2+ and Mg2+) and trypsinised with 1×trypsin/EDTA followed by 
neutralization with complete medium. Cell pellets were collected by 
centrifugation at 200×g for 2 min and resuspended in STO medium. Cells were 
counted and plated into gelatin-coated tissue culture dishes at a density of 5×104 
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cells/cm2. Prior to plating the mESCs, feeder cells were washed once with 1×PBS 
(without Ca2+ and Mg2+). 
 
2.4 Sub-culture of STO and mESCs 
STO cells were maintained in 10 cm tissue culture dishes at 37oC in a humidified 
incubator with 5% CO2. Cells were passaged twice per week at a split ratio of 
1:4−1:6 until reaching passage 15.  
 
mESCs were maintained in the 6-well feeder plates at 37oC in a humidified 
incubator with 5% CO2. Cells were passaged every other day at a split ratio of 
1:6−1:10 until reaching passage 40. 
 
For sub-culturing, cells were washed once with 1×PBS (without Ca2+ and Mg2+) 
and trypsinised with 1×trypsin/EDTA followed by neutralization with complete 
medium. Following the centrifugation at 200×g for 2 min, supernatants were 
discarded and cell pellets were resuspended in specific culture medium. For STO 
cells, the cell suspension was transferred into 10 cm tissue culture dishes; for 
mESCs, cell suspension was transferred into the previously prepared STO feeder 
plates.   
 
2.5 3-D EB system 
To make EBs, early passages of mESCs maintained on STO feeder plates were 
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sub-cultured in feeder-free gelatinised 6-well tissue culture plates for 48 h. Cells 
were trypsinised, pelleted and resuspended in mouse EB medium. The cell 
suspension was then plated in 90 mm bacterial petri dishes (Sterilin, 101VR20) at 
a specific seeding density. The EBs were maintained for up to 9 days. Medium 
was changed every other day (5 mL/dish). Each EB dish was split 1:2 split on day 
3 post plating. EB morphology and Bra-GFP expression was examined at specific 
time points (usually day 4 and 7). Experiments were performed in 3 independent 
biological replicates.  
 
2.6 2-D system 
Early passage Bra-GFP/Rosa26-E2C mESCs were harvested from feeder plates 
and sub-cultured in gelatinised 6-well tissue culture plates at a density of 5×104 
cells/cm2. Cells were incubated for 48 h followed by trypsinisation and re-plating 
into gelatinised 6-well plates at 1×105 cells/cm2 for 24 h. Cells were then 
harvested and re-plated into 60 mm tissue culture dishes at a density of 4.7×103 
cells/cm2 with overnight incubation in mESC medium. The following morning, 
medium was changed to NDiff® 227 (Clontech, Y40002) for 48 h and then NDiff® 
227 supplemented with Activin-A (R&d Systems, 338-AC) to a final 
concentration of 100 ng/L) and CHIR 99021 (Tocris, 4423) to a final 
concentration of 3 µM for a further 48 h incubation. Medium was changed on a 
daily basis. 
 
 
35 
 
 
 
C
ha
pt
er
 2
 
2.7 Flow cytometry analysis 
Single cell suspension in 1×PBS (1×106 cells/mL) was acquired by dissociating 
monolayer cell culture or aggregated EBs with 1×trypsin/EDTA similar to routine 
sub-culture protocols. Prior to the analysis, the suspension was filtered using a 40 
µm strainer (BD Falcon, 352340)   
  
To analyse the GFP+ cells within the Bra-GFP/Rosa26-E2C mESCs -derived EBs 
or 2-D differentiated monolayer cultures, cells were examined using a BD 
FACScalibur (BD Biosciences) flow cytometer according to manufacturer’s 
instructions, using a 488 nm laser to detect the GFP signal. For analysis of the 
GFP expression window in the EBs, wild-type E14TG2a-derived EBs were used 
as a negative control. For analysis of GFP expression in the 2-D system, 
undifferentiated Bra-GFP/Rosa26-E2C mESCs sub-cultured in gelatinised dishes 
in mESC medium for 24 h prior to induction were used as a negative control. Data 
were acquired by the BD CellQuest (BD Biosciences) software based on 104 
events and analysed using the Cyflogic (CyFlo Ltd) software.  
 
To determine the percentage of E2C+ cells in the routinely-cultured 
Bra-GFP/Rosa26-E2C mESCs, cells were analysed using a BD FACSCanto (BD 
Biosciences) flow cytometer. Untransfected E14-Bra-GFP mESCs were used as a 
negative control. Data output was performed using BD FACSDiva (version 6.1.3) 
software.  
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2.8 Fluorescence-activated cell sorting (FACS) 
FACS was used to isolate GFP+ mesodermal cells derived from 
Bra-GFP/Rosa26-E2C mESCs cultured in 3-D and 2-D systems. Single cell 
suspensions in 1×PBS (containing 100 mL/L Sigma fetal bovine serum, FBS) at a 
density of 1×107 cells/mL were obtained by dissociation with 1× trypsin/EDTA of 
day-6 EBs or day-4 2-D monolayer cultures. Sorting was performed using the BD 
FACSAria (BD Biosciences) flow sorter. Day-6 EBs derived from wild-type 
E14TG2a mESCs and undifferentiated Bra-GFP/Rosa26-E2C mESCs 
sub-cultured in gelatinised dishes in mESC medium for 24 h prior to induction 
were used as negative controls for 3-D and 2-D systems, respectively. Data output 
was performed using BD FACSDiva (version 6.1.3) software.  
 
2.9 Cell-IQ real-time imaging  
EBs were formed from the Bra-GFP/Rosa26-E2C mESCs at a seeding density of 
1.25×105 cells/mL and maintained in culture for up to day 9. On day 3 post plating, 
EBs were collected and plated onto solidified 2% agarose gel (20 g/L in 1×PBS) 
(Sigma, A9045) in glass bottom 6-well plates (MatTek, P06G-0-20-F). They were 
then embedded in a thin overlay of 1% agarose (10 g/L in EB medium). Each well 
was filled with 3 mL EB medium once the overlaid gels were set. Plates were 
sealed and maintained in Cell-IQ (Chip-Man Technologies Ltd) imaging facility. 
EBs were imaged by the Cell-IQ Imagen (Chip-Man Technologies Ltd) software 
on days 3 to 9 post plating on an hourly basis. Imaging data from both bright field 
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and 488 nm laser for the GFP fluorescence signal were documented. Raw data 
were analysed by the Cell-IQ Analyser (Chip-Man Technologies Ltd) and ImageJ 
(NIH) softwares. 
 
2.10 Mouse embryonic kidney rudiment ex vivo culture 
Kidneys were dissected from CD1 E13.5 mouse embryos and collected in a 1.5 
mL microfuge tube in ice cold rudiment dissection medium. Following media 
aspiration, kidneys were washed once with and re-suspended in 1×PBS, and 
transferred to a 15 mL conical tube. Once settled (by gravity), they were 
trypsinised at 37oC for a maximum of 15 min, with intermittent gentle tapping to 
disaggregate cells. Rudiment medium was added and the tube was incubated at 
37oC for 5 min to neutralise the trypsin. The tube was centrifuged at 1,800 ×g for 
2 min. Cell pellets were re-suspended in 1 mL kidney rudiment medium for cell 
counting. In the meantime, FACS-sorted Bra-GFP+ cells derived from mESC 2-D 
or 3-D culture systems were centrifuged and resuspended in rudiment medium 
and counted.  
 
A total of 2×105 cells were used in each rudiment, wherein kidney rudiment cells 
and Bra-GFP+ cells were mixed at a ratio of 1:9 in 0.5 mL microfuge tubes 
followed by centrifugation at 1,800 ×g for 2 min. Cell pellets were gently 
removed from the tube wall and transferred onto the pre-cut Isopore Membrane 
Filter (Merck Millipore, RTTP02500) on metal grids in the 6-well plates. 
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Rudiments were cultured in rudiment culture medium with Rho-associated, 
coiled-coil containing protein kinase inhibitor (ROCKi, Y-27632, Merck Millipore, 
688001) for 24 h followed by a further 4-day in the absence of ROCK inhibitor. 
Controls were also set up, including kidney rudiments comprising GFP+ mouse 
neonatal kidney-derived stem cells (GFP-KSCs) (1:9 ratio of KSC: kidney 
rudiment cells), reaggregated kidney rudiments (formed by kidney rudiment cells 
only), and intact kidney rudiments. Experiments were performed in 3 independent 
biological replicates. 
 
2.11 Administration and imaging of Bra-GFP/Rosa26-E2C 
Bra-GFP/Rosa26-E2C and untransfected E14-Bra-GFP mESCs were harvested 
from the feeder plates and expanded in 10 cm gelatinised tissue culture dishes and 
cultured for 48 h to reach the required density. Cells were then trypsinised and 
pelleted following the routine tissue culture protocols.  
 
Following a quick rinse with 1×PBS, cells were re-suspended in 1×PBS and 
counted. In a separate pilot experiment prior to the in vivo administration, E2C 
reporter pellets of 2 and 8×106 cells, respectively, were analysed using the IVIS® 
Spectrum Imaging System (PerkinElmer) to determine the level of E2C 
fluorescence. Cells were injected in 100 µL of PBS. The cell resuspensions were 
stored on ice immediately prior to in vivo administration. 
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Three female CB17 severe combined immunodeficient (SCID) mice (Charles 
River) were housed in accordance with the guidelines. Experiments were 
performed following the approved guidelines under a UK Home Office licence 
(Licence Number: 70/8741) under the Animals (Scientific Procedures) Act 1986 
and approved by the University of Liverpool Animal Ethics Committee. At the 
age of 8−10 weeks old, mice were used for mESCs injection. Animals were 
anaesthetised with isoflurane and shaved to remove back fur. mESCs in 100 μL of 
1×PBS were administered to the dorsal flank of individual mouse via 
subcutaneous injection at four different positions (top left, top right, bottom left 
and bottom right). 
 
The following doses of 10, 7.5 and 5×106/100 µL Bra-GFP/Rosa26-E2C mESCs 
were injected in to three of the positions in a random manner. 10×106/100 µL 
untransfected E14-Bra-GFP mESCs were individually injected alongside the 
Bra-GFP/Rosa26-E2C engrafts in the same mouse as negative controls. 
Experiments were performed in three independent biological replicates. Data of 
the signal intensity in terms of the values measured at the regions of interest (ROI) 
were acquired on day 0, 1, 4, 7 and 9 post injection using the IVIS® Spectrum In 
Vivo Imaging System (PerkinElmer) and analysed with its Living Image® 
software.  
 
2.12 Tumour volume measurement  
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Following the injection, the tumour size was measured using a digital caliper on 
day 4, 7 and 9 in terms of the length, width and height of the tumours. The length 
was measured in the direction of the dorsal longitude; the width was measured 
along the dorsal latitude; and the height was measured perpendicularly in-between 
the surface of the back and the upper surface of the tumours. 
 
2.13 Fixation 
For routinely-cultured cells 
Medium was aspirated. Cells were washed once with 1×PBS followed by fixation 
with 4% paraformaldehyde (PFA) (Sigma-Aldrich, P6148) at room temperature 
for 5- min. Samples were washed three times with 1×PBS and stored for up to 1 
week in 1×PBS at 4°C for immunofluorescence. 
 
For EBs 
EBs were collected into conical tubes and allowed to settle under gravity. Medium 
was discarded followed by fixation with 4% PFA at room temperature for 20 (day 
4−7) or 30 (day 8−9) min. EBs were then washed three times with 1×PBS. 
 
For mouse embryonic kidney rudiments 
Day 0 and 5 rudiments together with the membrane were transferred to the 
24-well plates and fixed with 4% PFA at room temperature for 15 min. Samples 
were gently washed once with 1×PBS and stored in 1×PBS at 4°C for 
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immunofluorescence.  
 
For dissected tumours 
Mice were sacrificed on day 9 when the tumours reached the size limit according 
to the Home Office guidelines. Tumours were harvested immediately afterwards 
and fixed with about 10-time volume of 4% PFA at 4°C overnight. If necessary, 
larger tumours were vertically cut into small pieces prior to fixation.  
 
2.14 Sectioning 
For EB frozen sections and tumours 
Fixed EBs/tumours were soaked in 15% sucrose at 4°C overnight followed by 
embedding in the 7.5% molten gelatin. Samples were mounted onto cork disks 
with Shandon™ Cryomatrix™ embedding resin (Thermo Fisher Scientific, 
6769006). They were then covered with embedding resin and cut with a cryostat 
at10–20 µm. Section and blocks were stored at at -80°C. 
 
For tumour frozen sections 
Fixed tumours were rinsed with 1×PBS followed by a concession immersing 
process of 15% and 30% sucrose at 4°C overnight, respectively. Tumours were 
then embedded with embedding resin and frozen in cryostat section machine. 10 
µm sections were prepared onto the slides and stored at -80°C. 
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For tumour paraffin sections 
Fixed tumours were rinsed with 1×PBS and transferred to 70% ethanol followed 
by a general paraffin embedding process (Hewitson and Darby, 2010). 5 µm 
sections slides were prepared.  
 
2.15 Tumour histopathological analysis  
Tumour paraffin sections were stained with haematoxylin and eosin (H&E) 
followed by histopathological examination.  
 
2.16 Immunofluorescence staining 
For routinely-cultured cells 
Bra-GFP/Rosa26-E2C and untransfected E14-Bra-GFP mESC lines were 
sub-cultured from STO feeder layers to gelatinised dishes for 48 h. They were 
then plated into 8-chamber slides/35 mm gelatinised dishes. When reaching the 
required density, they were fixed and then immunostained for stemness markers 
such as Oct4 and Nanog. Samples were blocked in 10% serum solution containing 
0.1% Triton-X 100 at room temperature for 1 h, and then incubated with the 
primary antibodies at specified concentrations at 4°C overnight. They were 
washed three times with PBS and incubated with secondary antibody solution in 
the dark at room temperature for 2 h. Detailed information of antibodies is listed 
in Table 2.2. All samples were then counter-stained with 4',6-diamidino-2- 
phenylindole (DAPI) (Thermo Fisher Scientific, D1306, 1:100,000) at room 
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temperature for 15 min. Slides were mounted with DAKO fluorescent mounting 
medium (Agilent Technologies, S3023) and sealed by nail polish. Controls were 
also included to check for non-specific binding of secondary antibodies, and these 
comprised samples where primary antibodies were omitted. Data were acquired 
using a Leica DM2500 (Leica) fluorescence microscope and the Leica Application 
Suite (LAS, Leica) integrated software. 
 
For mouse embryonic kidney rudiments 
Fixed rudiments on the membranes were blocked with 10% serum solution 
containing 0.1% Triton-X 100 at room temperature for 1 h, followed by 
incubation with primary antibodies for megalin, synaptopodin, Wt1, and 
E2-Crimson where necessary, at 4oC overnight. They were then incubated with 
secondary antibodies at 4oC overnight in the dark followed by counter-staining 
with 10 µg/µL rhodamine-labeled peanut agglutinin (PNA) (Vector, RL-1072) at 
room temperature for 1 h in the dark. Controls were also included as above to 
check for non-specific binding of secondary antibodies. Samples were mounted 
onto the slides using DAKO fluorescent mounting medium and sealed by nail 
polish. Data were documented by the Zeiss LSM 510 META (Zeiss) multiphoton 
confocal laser scanning microscope. Data analysis was performed by the ImageJ 
(NIH) software.  
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Table 2.2 List of antibodies used for immunofluorescence 
Targets Blocking Sera 
Primary 
Abs 
(dilutions) 
Catalogue 
No’s 
(suppliers) 
Secondary  
Abs  
(dilutions) 
Catalogue 
No’s 
(suppliers) 
E2C Chicken/ 
Goat 
Rabbit  
IgG 
(1:1,000) 
632496 
(Clontech) 
Chicken-anti-rabbit 
IgG 488 
or Goat-anti-rabbit 
594  
(1:1,000) 
AF A21441/ 
A11012 
(TFS)‡ 
Oct4 Goat Mouse 
IgG2b 
(1:500) 
sc-5279 
(Santa  
Cruz) 
Goat-anti-mouse 
IgG2b 488  
(1:1000) 
AF A21141 
(TFS) 
Nanog Chicken Rabbit  
IgG 
(1:500) 
ab80892 
(Abcam) 
Chicken-anti-rabbit 
IgG 488  
(1:1000) 
AF A21441 
(TFS) 
Megalin Goat/ 
Donkey 
Mouse  
IgG1 
(1:200) 
DM3613P 
(Acris) 
Goat-anti-mouse 
IgG1 488 
or 
Donkey-anti-mouse 
IgG (H+L) 647 
(1:1,000) 
AF A21121/ 
A31571 
(TFS) 
PECAM-1 Donkey Rat  
IgG2a,κ 
(1:100) 
550274 
(BD) 
Donkey-anti-rat IgG 
(H+L) 488  
(1:1,000) 
AF A21208 
(TFS) 
Synap- 
topodin 
Goat/ 
Donkey 
Mouse  
IgG1 
(1:2) 
65194 
(Progen) 
Goat-anti-mouse 
IgG1 488 
or 
Donkey-anti-mouse 
IgG (H+L) 647 
(1:1,000) 
AF A21121/ 
A31571 
(TFS) 
Wt1 Goat/ 
Donkey 
Mouse  
IgG1 
(1:100) 
05-753 
(Merck 
Millipore) 
Goat-anti-mouse 
IgG1 488 
or 
Donkey-anti-mouse 
IgG (H+L) 647 
(1:1,000) 
AF A21121/ 
A31571 
(TFS) 
‡ AF, Alexa-Fluor; TFS, Thermo Fisher Scientific 
 
For EB and tumour frozen sections 
EB or tumour frozen section slides were blocked in 10% serum solution(s) and 
incubated with primary antibody solutions in a humidified chamber at room 
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temperature for 1 h, followed by incubation with E2-Crimson and/or PECAM-1 
primary antibodies at 4°C overnight. The remaining steps followed the protocols 
for routinely-cultured cells.  
 
2.17 Linearisation of the gene targeting construct 
The targeting construct pDEST-ROSA26-E2C employed in this study was 
prepared by Dr. Antonius Plagge (University of Liverpool) and generated by using 
two vectors which were kindly given as gifts by Dr. Shinichi Aizawa’s group 
(RIKEN, Japan) and Dr. Peter Hohenstein (University of Edinburgh), respectively. 
Based mainly on Hohenstein’s vector, an 8.1 kb 5’-HA and a 3.5 kb 3’-HA was 
cloned from Aizawa’s construct to replace the original 1 kb 5’-HA and 5 kb 3’-HA, 
respectively.  
 
50 µg pDEST-ROSA26-E2C plasmid DNA was digested by PvuI FastDigest® 
restriction enzyme (Thermo Fisher Scientific, FD0624) in 1×FastDigest® Green 
buffer (Thermo Fisher Scientific, B72). The reaction mixtures were incubated at 
37°C for 2 h and further at -20°C overnight. The product was examined by 8 
cm-length 0.8% agarose gel electrophoresis at 7 V/cm for 3 h in 1×TAE buffer, 
with the λ DNA/Hind III ladder ( Thermo Fisher Scientific, 15612013) as a sizing 
marker to check the efficacy of the enzyme digest. Gel slices were collected and 
linearised DNA fragments were extracted and purified by Wizard® SV Gel and 
PCR Clean-Up System (Promega, A9282) according to the manufacturer’s 
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protocols. DNA concentrations and purity were determined using a NanoDrop 
2000 (Thermo Fisher Scientific, ND-2000). Where necessary, an ethanol 
precipitation was performed to further concentrate linearised DNA. Purified 
linearised DNA was dissolved in 1×TE buffer and stored at -20°C.  
 
2.18 Generation of the knock-in mESC reporter line 
E14-Bra-GFP mESCs at passage 7 were expanded in 10 cm feeder dishes. When 
reaching approximately 70% confluence, cells were trypsinised, pelleted and 
resuspended in 1×PBS (without Ca2+ and Mg2+). The cell suspension was mixed 
with linearised targeting construct (DNA final concentration 1 µg/µL) and was 
transferred into cuvettes (800 µL each) for electroporation (240 V, 7.6 ms). 
Following the electroporation, cells were placed on ice and gently pipetted once 
by adding an extra 1 mL of mESC medium. Cell suspension was transferred to 10 
cm feeder dishes and incubated at 37oC in a humidified incubator with 5% CO2. 
Two days post electroporation, G418 (Sigma, A1720) was added into the culture 
medium at a final concentration of 200 µg/mL, initiating the counter-selection 
process. Medium was changed daily and supplemented with G418 till day 9 of the 
selection. Viable colonies were picked and transferred to 96-well non-treated 
round-bottom plates containing 1×trypsin/EDTA (one colony per well). Colonies 
were dissociated and mESC medium was added to neutralise the trypsinisation. 
The solution was then transferred to 96-well tissue culture plates prepared with 
feeder cells and incubated at 37oC in a humidified incubator with 5% CO2. After 
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24 h expansion, cells in each well were trypsinised and neutralised with mESC 
medium to reach a total volume of 200 µL per well, 100 µL of which being 
transferred to gelatinised 24-well tissue culture plates for screening purpose whilst 
the remaining being sealed and frozen at -80oC for subsequent expansion. 
 
2.19 Genomic DNA extraction of mESCs 
mESC pellets were collected in 1.5 mL microfuge tubes from dishes/plates 
following routine sub-culture protocols. They were resuspended in lysis buffer 
containing 100 µg/mL Proteinase K (Sigma, P6556) and incubated at 55oC 
overnight. One volume of 2-propanol was added followed by centrifugation at 
16,000 ×g for 1 min to obtain the genomic DNA (gDNA) as pellets. gDNA were 
washed twice with 70% ethanol and air dried. They were then re-dissolved in 
1×TE buffer at 4oC overnight followed by 65oC for 15 min. DNA concentrations 
and purity was measured using NanoDrop 2000.  
 
2.20 3’-homologous arm PCR analysis 
3’- homologous arm (HA) PCR analyses were performed on the gDNAs of viable 
colonies expanded in 96-well feeder plates using a GoTaq® Long PCR reaction 
system (Promega, M4021) according to the manufacturer’s manual. Detail of the 
composition of the PCR reaction system is listed in Table 2.3. gDNA template 
from untransfected E14-Bra-GFP mESCs served as the negative control. A 
non-template control was also included where template gDNA was substituted by 
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nuclease-free H2O. PCP primer sequences were: 
5’-GGCTTCTGAGGCGGAAAGA-3’ (forward); 
5’-CAACAATCAGCCTAAGGTAG-3’ (reverse).  
 
Table 2.3 Composition of the GoTaq® Long PCR reaction system 
Components Final Volume/Concentration 
GoTaq® Long PCR Master Mix, 2× 1× 
Forward/Reverse primers     50 µmol/L 
gDNA template*  500 ng 
Nuclease-free H2O adjusted to a final volume of  25 µL 
*For non-template control, the template gDNA was substituted by nuclease-free H2O. 
 
PCR amplification was performed by the G-STORM GS1 Thermal Cycler 
(G-Storm). The PCR programme was set up as follows: 
 
Hot start at 95°C for 2 min, followed by PCR steps comprising denaturation at 
94°C for 30 s, annealing at 65°C for 30 s, elongation at 65°C for 4 min, and final 
extension at 72°C for 10 min, for 30 cycles. Products were examined using 8 
cm-length 0.8% agarose gel electrophoresis at 7 V/cm for 45 min in 1×TAE buffer, 
with 1 kb DNA ladder (Fisher Scientific, 15615-016) as a sizing marker to verify 
product molecular sizes. 
 
2.21 Analysis of E2C expression in the PCR screened positive clones with 
fluorescence microscopy 
Screened clones were plated on gelatin for 48 h and re-plated in gelatinised 
 
49 
 
 
 
C
ha
pt
er
 2
 
8-chamber slides for culture. When reaching required colony size, they were fixed 
with 4% PFA followed by counter staining with DAPI as for immunofluorescence 
staining. After mounting, slides were examined by the Leica DM2500 (Leica) 
fluorescence microscope with the 561 nm laser and data were acquired by the 
Leica Application Suite (LAS, Leica) integrated software. STO feeder cells as 
well as untransfected and tdTomato-transduced E14-Bra-GFP mESCs were 
included as negative and positive controls, respectively. 
 
2.22 Real-time reverse transcription-PCR of mRNA isolated from 
Bra-GFP+ and Bra-GFP- cells derived from 3-D and 2-D culture 
systems 
Quantitative real-time polymerase chain reaction (RT-qPCR) was performed using 
the Fast SYBR® Green Cells-to-CT™ Kit (Thermo Fisher Scientific, 4405659). 
Cell lysis, reverse transcription and qPCR amplification was performed according 
to the manufacturer’s protocols. The reaction system was set up as described in 
Table 2.4.  
 
Table 2.4 Composition of the Fast Real-time PCR reaction system 
Components Final Volume/Concentration 
Fast SYBR® Green PCR Master Mix 10 µL 
Forward/Reverse primers  312.5 nmol/L 
RT Reaction template*  4 µL 
Nuclease-free H2O adjusted to a final volume of 20 µL 
*For non-template control, the template cDNA was substituted by nuclease-free H2O. 
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Three biological replicates for the Bra-GFP+ populations isolated from 3-D and 
2-D systems, and two biological replicates for Bra-GFP- populations derived from 
the 3-D and 2-D systems were assessed. For each RT reaction product analysed, 
two technical replicates were prepared. RT-qPCR reaction was performed using 
the BioRad CFX Connect Real-time PCR Detection instrument. The PCR 
programme was set up as follows: 
 
The amplification steps were DNA polymerase activation at 95°C for 20 s, 
denaturation at 95°C for 3 s and annealing/extension at 60°C for 30 s. A melting 
curve was generated at the end of the 40th PCR cycle. The melting curve steps 
were 95°C denaturation for 10 s, 65°C annealing for cycles of 0.5°C increments 
every 5 s to detect the product melting temperature starting from 65°C to 95°C. 
Data were acquired using the incorporated Bio-Rad CFX Manager (version 3.1) 
software. Changes in the relative gene expression level and statistical analysis 
were also performed using the software, where p<0.05 was considered statistically 
significant. Primer information is shown in Table 2.5. Amplification annealing 
temperature (Ta) was 60°C for all primers. PCR reaction products were verified 
by 0.8% agarose gel electrophoresis at 7 V/cm with 100 bp HyperLadder™ IV 
(BIO-33029, Bioline) as sizing marker for amplicons molecular size (Appendix 
Figure 1). Non-template control (NTC) was performed for each analysed gene and 
the non-reverse transcriptase (NRT) control was also included to verify the 
elimination of gDNA. 
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Table 2.5 List of RT-qPCR primers* 
Genes 
Forward 
Sequences 
Reverse 
Sequences 
Amplicons 
Size (bp) 
References 
Bra CATCGGAACAGC
TCTCCAACCTAT 
GTGGGCTGGCGT
TATGACTCA 
136 RTPrimerDB 
β-actin GTACCCAGGCAT
TGCTGACA 
CTGGAAGGTGGA
CAGTGAGG 
145 
In-house 
Gapdh CATCTTCCAGGA
GCGAGACC 
GAAGGGGCGGA
GATGATGAC 
150 
Fgf5 AAGTCAATGGCT
CCCACGAA 
TCCTCGTATTCCT
ACAATCCCCT 
88 
Foxd1 CAAGAATCCGCT
GGTGAAGCC 
ACAGGTTGTGAC
GGATGCTG 
88 
Foxf1 CCAAAACAGTCA
CAACGGGC 
TCACACACGGCT
TGATGTCT 
191 
Gdnf CGCTGACCAGTG
ACTCCAAT 
AAACGCACCCCC
GATTTTTG 
222 
Nanog AAGCAGAAGATG
CGGACTGT 
GTGCTGAGCCCT
TCTGAATC 
232 
Oct4 TGGAGACTTTGC
AGCCTGAG 
CTTCAGCAGCTT
GGCAAACTG 
188 
Osr1 GCCCCCAAAAAG
GAGAGAGT 
AGCCACAGCTCA
TCCTTTACC 
161 
Pax2 TCCAGGCATCAG
AGCACATC 
GGCCGATGCAGA
TAGACTGG 
104 
Wt1 AATGCGCCCTAC
CTGCCCA 
CCGTCGAAAGTG
ACCGTGCTGTAT 
116 
Cdx2 QT00116739 114 
Qiagen 
Tbx6 QT00098861 80,80,157 
Lhx1 QT01660792 87 
Foxa2 QT00242809 115 
Hoxa10 QT00240212 61 
Hoxa11 QT00250404 97 
Hoxb1 QT00493906 128 
Hoxc9 QT00113218 138 
Hoxd11 QT00267337 97 
* Annealing temperature (Ta) was 60°C for all primers. 
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2.23 Statistical analysis 
Data were analysed using Microsoft Excel or GraphPad Prism (version 5.01, 
GraphPad Software), except for the RT-qPCR data which were analysed by the 
Bio-Rad CFX Manager software. Processed data were plotted by GraphPad Prism. 
For the statistical analysis of all the data, the same number/replicates were 
analysed. Basic functions used were: mean, standard deviation (SD), standard 
error of the mean (SEM) and Student’s t-test.  
 
2.24 Composition of tissue culture media 
 
Table 2.6 List of media and composition 
Media                   Composition 
STO 
culture  
medium 
 
Dulbecco's Modified Eagle's Medium (DMEM) (Sigma, D6546) 
100 mL/L  FBS (Gibco, 10270) 
10 mL/L  MEM non-essential amino acid (Sigma, M7145) 
10 mL/L  L-glutamine (Sigma, G7513) 
mESC 
culture  
medium 
 DMEM (Sigma, D6546) 
150 mL/L  FBS, Sigma, F2442) 
10 mL/L  MEM non-essential amino acid (Sigma, M7145) 
10 mL/L  L-glutamine (Sigma, G7513) 
0.1 mmol/L  β-mercaptoethanol (Gibco, 31350) 
1,000 U/mL  Mouse LIF (Merck Millipore, ESG1107) 
Mouse EB 
culture 
medium 
  DMEM (Sigma, D6546) 
100 mL/L  FBS (Sigma, F2442) 
10 mL/L  MEM non-essential amino acid (Sigma, M7145) 
10 mL/L  L-glutamine (Sigma, G7513) 
0.1 mmol/L  β-mercaptoethanol (Gibco, 31350) 
(continued on next page) 
 
 
53 
 
 
 
C
ha
pt
er
 2
 
(continued from previous page) 
 
Table 2.6, continued. 
Media                   Composition 
mESC freezing 
medium (2×, for 
96-well plates) 
400 ml/L  mESC medium 
400 mL/L  FBS (Gibco, 10270) 
200 ml/L  DMSO (Sigma, D2650) 
Mouse  
KSC  
Culture 
medium 
  DMEM (Sigma, D6546) 
100 mL/L  FBS (Gibco, 10270) 
10 mL/L  MEM non-essential amino acid (Sigma, M7145) 
10 mL/L  L-glutamine (Sigma, G7513) 
0.1 mmol/L  β-mercaptoethanol (Gibco, 31350) 
Rudiment 
dissection  
medium 
 MEME (Sigma, M5650) 
10 mL/L  FBS (Gibco, 10270) 
Rudiment  
culture 
medium 
  MEME (Sigma, M5650) 
100 mL/L  FBS (Gibco, 10270) 
10 mL/L  L-glutamine (Sigma, G7513) 
10 mL/L  Penicillin/Streptomycin (Gibco, 15140122) 
 
 
2.25 Composition of buffers 
 
Table 2.7 List of buffers and composition 
Solutions             Composition 
1× TAE buffer 
(pH 8.0) 
40mmol/L  Tris base 
5mmol/L  Sodium acetate 
1mmol/L  Ethylenediaminetetraacetic acid (EDTA) 
1× Cell lysis 
buffer 
(pH8.5) 
100 mmol/L Tris base 
 5 mmol/L  
 
EDTA 
200 mmol/L  
 
NaCl 
2 g/L Sodium dodecyl sulphate (SDS) 
  
 
 
 
 
54 
 
 
 
55 
C
h
a
p
te
r 
3
 
Chapter 3   
 
Generation of the Bra-GFP/Rosa26-E2C mESC reporter 
line 
                                                                   
 
3.1 Introduction 
A key aim of this project was to characterize Bra
+
 nascent mesoderm derived from 
mESCs cultured in 3-D as EBs or in 2-D differentiation culture conditions. An 
important part of the characterization was to investigate the differentiation 
potential of the mesodermal cells in (i) mouse kidneys in vivo, and (ii) mouse 
kidney rudiments ex vivo, as previously undertaken by our group (Rak-Raszewska 
et al., 2012a). To this end, it was important to be able to specifically select Bra
+
 
cells from the mESCs cultured under both the 3-D and 2-D conditions, and to 
track the mesodermal cells in vivo and ex vivo. In order to select Bra
+
 cells, we 
made use of a Bra-GFP mESC line where GFP is expressed from within the 
brachyury locus, enabling mesodermal cells to be selected using fluorescence 
activated cell sorting (FACS) (Fehling et al., 2003). To enable the GFP
+
 
mesodermal cells to be tracked both in living mice and in kidney rudiments ex 
vivo, we introduced the far-red fluorescent protein, E2-Crimson (E2C) (Strack et 
al., 2009), into the constitutively active Rosa26 locus of the Bra-GFP mESCs 
(Friedrich and Soriano, 1991). E2C has excitation and emission maxima of 611 
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nm and 646 nm, respectively, making it suitable for imaging in the near-infrared 
window (Strack et al., 2009). It has a number of advantages over other far-red 
fluorescent proteins, in that it is very bright (extinction coefficient of 126,000 
M
-1
/cm), has good photostability, and in various cell types, has shown limited 
phototoxicity (Strack et al., 2009; Christensen et al., 2015). Furthermore, it has 
been recently demonstrated that breast cancer cells expressing E2C could be 
imaged within rat lungs in vivo, suggesting that E2C is suitable for tracking cells 
in vivo in small rodents (Christensen et al., 2015). To introduce the E2C reporter 
into the Rosa26 locus of the Bra-GFP mESC line, we used a homologous 
recombination approach outlined below. After the E2C reporter line had been 
generated, the mESCs were assessed to ensure that the expression of key mESC 
markers (i.e., Oct4 and Nanog) was not affected. Furthermore, the E2C reporter 
cells were checked to ensure they were still able to differentiate by ensuring they 
were able to form typical EBs. 
 
Using homologous recombination to generate a transgenic mESC reporter 
line 
Rosa26 is located on mouse chromosome 6 and spans approximately 9 kb 
(Monticelli, 2010). It comprises three exons and generates two non-coding and 
one highly-conserved anti-sense transcript encoding no protein product 
(Zambrowicz and Soriano, 1997). The Rosa26 locus was originally identified by 
Soriano’s group in the promoter-trap screening by integrating the β-geo (fused 
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β-gal and neo) cassette into mESCs derived from the 129Sv mouse strain via a 
retroviral targeting vector named ROSAβ-gal (reverse orientation splice acceptor 
β-gal). The resulting mutants showed constitutive and ubiquitous expression of a 
single copy of the transgene in all tissues at all pre- and post-natal developmental 
stages of the germ-line chimeric mice, albeit at different levels of expression. 
Moreover, none of the progeny exhibited any obvious phenotype (Friedrich and 
Soriano, 1991). Taken together, these reports highlight the usefulness of Rosa26 to 
construct stable reporter mESC lines for tracking cells following transplantation 
(Soriano, 1999).  
 
Soriano’s strategy has provided a common approach for introducing transgenes 
into pluripotent mESCs. In brief, the strategy involves constructing a knock-in 
vector that contains the exogenous reporter gene cDNA sequence preceded by an 
adenoviral splice acceptor sequence, a positive selection marker (usually a 
neomycin resistance gene cassette), the Rosa26 5’- and 3’-homology arms (HAs) 
flanking the aforementioned elements, and a negative selection marker 
(commonly a diphtheria toxin A subunit, DTA). During the recombination 
between the Rosa26 homology arms, the transgene integrates into the first intron 
of Rosa26 at a unique XbaI site and is expressed constitutively under the control 
of the Rosa26 promoter. The selection markers are expressed independently by 
assigned promoters, respectively. Incorrect recombinants have either the 
inactivation of neo expression or activation of DTA insertion which are lethal to 
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cells during counter selection. Viable clones that have correct integration of the 
targeting construct can be screened out following the selection. They can then be 
analysed by PCR amplification of cDNA sequences of the exogenous reporter 
gene as well as the genomic DNA sequences of the homologous arms (Abe et al., 
2011; Hohenstein et al., 2008).  
 
E14-Bra-GFP mESC line 
The E14-Bra-GFP mESC line used in this study was a generous gift from Dr. 
Georges Lacaud at the Paterson Institute for Cancer Research, Manchester 
(Fehling et al., 2003). This mESC line was generated by knocking an eGFP mini 
gene into the locus of the pan-mesoderm marker Bra of the E14.1 cell line derived 
from blastocysts of the 129/Ola mouse strain (Hooper et al., 1987).  
 
During the knock-in, the targeting vector was linearised and electroporated into 
the Bra-GFP mESCs followed by counter selection. Viable colonies were picked 
and expanded. Genomic DNA samples were collected for 3’-HA PCR analysis. 
Screened clones were thawed and expanded to examine expression of E2C.  
 
The objectives of this chapter were to: 
1. Linearise the targeting construct; 
2. Undertake knock-in of the E2-Crimson transgene into the Rosa26 locus; 
3. Perform 3’-HA PCR screening for correctly targeted recombinants; 
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4. Analyse E2C expression in screened positive clones using fluorescence 
microscopy; 
5. Analyse E2C expression using flow cytometry; 
6. Assess the stemness and differentiation potential of the 
Bra-GFP/Rosa26-E2C mESC reporter line. 
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3.2 Results 
3.2.1 Linearisation of targeting construct 
To improve transfection efficiency, the first step was to linearise the targeting 
plasmid. PvuI restriction enzyme digestion was therefore performed to linearise 
the vector and also release the targeting construct from the vector backbone. 
Following electrophoresis, a clear DNA band of approximately 19 kb showed 
successful PvuI restriction enzyme digestion of the targeting vector DNA (Figure 
3.1). The smaller fragment produced simultaneously by this digestion would not 
be observed on this fragment range of the gel electrophoresis image. The results 
demonstrated that the linearised pDEST-ROSA26-E2C plasmid DNA fragment 
was acquired for knock-in. 
 
 
 
 
Figure 3.1 0.8% agarose gel electrophoresis of linearised pDEST-ROSA26-E2C 
plasmid DNA fragment confirmed purity following PvuI restriction enzyme digestion 
and DNA extraction. Sample was loaded on an 8 cm-length 0.8% agarose gel run at 7 
V/cm for 3 h in 1×TAE buffer. 
 
3.2.2 Rosa26 knock-in of E2-Crimson transgene 
The linearised targeting construct was electroporated into E14-Bra-GFP mESCs  
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Figure 3.2 Schematic illustration of Schematic illustration of the Rosa26 knock-in 
strategy and E14-Bra-GFP mESC chromosome with correct targeted insertion of 
pDest-ROSA26-E2C targeting vector. The vector contains two homology arms (HAs) 
that flank the E2-Crimson cassette that has a poly A (pA) additional signal, which will stop 
any further transcription downstream of the targeted insertion, and a downstream positive 
drug selection marker neo (Neomycin resistance). The insertion site in-between the HAs is 
identified by the XbaI restriction enzyme site. A lethal negative selection marker DTA is 
placed in the 5’ upstream region adjacent to the targeting arm. The PuvI restriction 
enzyme sites are located in the vector backbone. When linearised for gene targeting, most 
of the vector backbone will be removed following PuvI restriction digestion. A loxP site 
(indicated with a green triangle) is located next to the 5’ HA for future Cre-mediated 
recombination. FLP recombinase target (FRT) sites (indicated with blue arrow heads) 
flanking the neo cassette are designed for future manipulation with flippase (FLP) 
recombinase. In the correct recombinants, E2C cDNA is introduced into the Rosa26 locus 
and is expressed under the control of the Rosa26 promoter. The neo gene is also 
introduced into the Rosa26 locus whereas the DTA cassette is lost. Clones that had an 
integrated DTA cassette would be killed by the toxin during the selection process. 
Neomycin expression is under the control of its own promoter within the cassette, which 
facilitates cell survival during G418 selection. Neo-deficient clones were depleted due to 
the loss of G418 resistance. Green arrows show the forward and reverse primer-binding 
sites for the designated 3’-HA screening.  
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and a 9-day counter selection was undertaken, following which, 244 viable clones 
were picked individually and were then expanded and cryopreserved in 96-well 
plates. It was assumed that the correct clones would only contain E2C and neo 
cassettes within intron 1 of the Rosa26 locus (Figure 3.2).   
 
3.2.3 3’-HA PCR screening for correctly targeted recombinants 
In order to examine whether the viable clones were integrated correctly as a single 
copy cassette, we chose 35 expanded clones in a random manner for PCR analysis. 
3’-HA PCR screening was applied to the gDNA templates from the 35 clones. Gel 
electrophoresis results showed significant bright bands in 18 of 35 clones, weaker 
DNA bands from 2 of 35, and no band with the remaining 15 clones as well as the 
control templates (Figure 3.3). The 18 clones with bright bands and the 2 with 
weaker bands showed the correct PCR product size of approximately 3.4 kb and 
thus were considered as positive recombinants. Positive recombinants comprised 
just over 50% of the resultant clones.     
 
3.2.4 Analysis of E2C expression in screened positive clones using 
fluorescence microscopy 
Following the 3’-HA PCR screening, the 18 positive and 3 randomly selected 
negative clones were individually expanded from the 96-well cryopreserved plates. 
Viable clones were sub-cultured in 8-chamber tissue culture slides and observed 
under a fluorescence microscope to investigate whether they expressed the E2C 
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transgene. The five positive clones were found to be fluorescent, and their 
intensity was comparable to that of tdTomato-transduced E14-Bra-GFP mESCs 
(produced in house). No fluorescence signal was detected within the negative 
clone wells (Figure 3.4).   
 
 
 
 
Figure 3.3 0.8% agarose gel electrophoresis of a total of 35 viable clones. PCR was 
performed with 25 µl GoTaq® Long PCR Master Mix system. 500 ng gDNA templates 
(numbered as ①-I-A to D and ①-II A to B) were amplified at the annealing temperature of 
65°C for 30 cycles, with gDNA template from untransfected (Untft) E14-Bra-GFP mESCs 
cultured on gelatin as negative control. A non-template control (NTC) was also included 
where template gDNA was substituted by nuclease-free H2O. Yellow stars show 3’-HA 
screened positive clones with bright bands (18 of 35) and blue arrow heads show positive 
clones with weaker bands of the correct size of 3,380 bp (2 of 35). Sample was loaded on 
an 8 cm-length 0.8% agarose gel run at 7 V/cm for 45 min in 1×TAE buffer. L,1 kb ladder. 
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Figure 3.4 E2C expression was examined by fluorescence microscopy in 3’-HA 
PCR-screened positive and negative clones. Five positive clones were named 
according to their address in the 96-well plate (i.e., +B5, +C4, +D1, +E3, +G1). 
tdTomato-transduced E14-Bra-GFP mESCs were used as a positive control with STO 
feeder cells, untransfected (untft) E14-Bra-/GFP mESCs and a negative clone named –B2 
comprised the negative controls. All samples were counter-stained with the nuclear stain 
DAPI. Scale bar, 100 µm (all graphs). 
(continued on next page) 
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(continued from previous page) 
 
 
 
Figure 3.4, continued. 
 
3.2.5 Flow cytometry analysis of E2C expression 
In order to confirm that all cells within the positive clones expressed E2C, 4 of the 
E2C-expressing clones, namely +B5, +C4, +D1 and +E3, were selected for flow 
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cytometry analysis. The average E2C signal intensity of all the 4 clones was 
approximately 10
3
. For Clones +B5, +C4 and +E3, over 93% of the population 
expressed E2C (data not shown), whereas 99% of clone +C4 expressed E2C, 
indicating a very high purity. +D1 comprised a smaller proportion (87%) of 
E2C-expressing cells (Figure 3.5). Apart from the fact that only 87% cells of the 
clone +D1were E2C positive, it also appeared that the mean fluorescence intensity 
was lower in this clone (375) than in the +C4 (729). +C4 was therefore selected 
for subsequent experiments.  
 
 
 
Figure 3.5 Flow cytometry analysis of E2C expression of the selected 3’-HA 
PCR-screened positive clones. Untransfected E14-Bra-GFP mESCs and a negative 
clone named –B2 was used as the negative control. 10,000 events were counted for each 
sample. 
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3.2.6 Stemness and differentiation potential of Bra-GFP/Rosa26-E2C mESC 
reporter line 
To ensure the knock-in of E2C did not affect self-renewal or differentiation 
capacity, the cells were assessed for the expression of stemness markers and their 
ability to generate EBs. To examine the expression of stemness markers, the clone 
+C4 was plated into 8-chamber slides/35 mm dishes for immunofluorescent 
staining of Oct4 and Nanog. The results demonstrated specific nuclei 
located-staining of Oct4 and Nanog, respectively, of the +C4 colonies (Figure 
3.6).  
 
To evaluate whether typical EBs can be formed following the E2C knock-in 
manipulation, a specified density of cells from clone +C4 colonies were plated in 
bacterial petri dishes and cultivated for 7 days in EB medium. Aggregates were 
observed during the first 24 to 48 h followed by the formation of an outer PrEn 
layer. Cavitation was observed in the majority of EBs by day 7 (Figure 3.7). BM, 
PrEc, VEn and PEn were also identifiable by day 7 in the cavitated EBs, 
suggesting that the +C4 cells had retained their ability to differentiate to different 
lineages. 
 
 
 
 
 
 
 
 
 
 
 
68 
C
h
a
p
te
r 
3
 
 
 
 
Figure 3.6 Expression of stemness markers Oct4 and Nanog was confirmed by 
immunofluorescent staining of clone +C4.  All samples were counter-stained with 
DAPI. Yellow arrow heads show STO feeder cell nuclei. Scale bar, 100 µm (all graphs). 
. 
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Figure 3.7 Differentiation potential of clone +C4 was confirmed by typical EB 
formation. Cells were seeded in suspension culture dishes up tol day 7. PrEc, primitive 
ectoderm; PrEn, primitive endoderm; BM, basement membrane; Cav, cavity; VEn, visceral 
endoderm; PEn, parietal endoderm. Scale bar, 400 µm (all graphs). 
 
3.3 Discussion 
In this study, an E2C-expressing E14-Bra-GFP mESC reporter line (clone +C4) 
was generated by knocking-in E2C into the Rosa26 locus.  
 
Using Soriano’s strategy, it has been reported that the targeting efficiency of the 
Rosa26 locus is around 20% of drug-resistant colonies (Monticelli, 2010). By 
using Hohenstein’s protocol, the efficiency can be increased to an average of 25% 
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(Hohenstein et al., 2008). However, by using Aizawa’s vector that contains longer 
5’- and 3’-HAs, it has been reported that the efficiency can be as high as 45%, 
which is consistent with the results obtained here (i.e., 51% of drug-resistant 
clones appeared to have undergone correct homologous recombination) (Abe et 
al., 2011). It is likely that the increase in efficiency observed using Aizawa’s 
vector is due to the longer length of the homologous arms (Thomas and Capecchi, 
1987; Deng and Capecchi, 1992). Aizawa’s vector contains an 8.1 kb 5’-HA and a 
3.5 kb 3’-HA whereas the HAs in Hohenstein’s vector are only 1 kb for the 5’-HA 
and 5 kb for the 3’-HA (Abe et al., 2011; Hohenstein et al., 2008). Although the 
efficiency appeared to be high within our results, the screening design could be 
further optimised in order to exclude random vector integration. PCR screening 
along with Southern blot analysis on 5’-homologous recombination would be of 
further consideration (Abe et al., 2011; Hohenstein et al., 2008; Liu et al, 2011; 
Tong et al, 2011). This would produce bands for distinguishing whether correct 
recombination has occurred within the targeted locus. Aside from that, it would be 
ideal to perform amplicon sequencing comparing between screened clones and 
non-transfected cells to verify integration integrity (Shen et al, 2013).  
 
Interestingly, there were two screened clones which showed positive PCR 
amplicon bands, but unlike the other positive ones, the intensity was significantly 
reduced, implying a lower expression level. This might be due to less template 
DNA of PCR or impurity carried over from genomic DNA. Another possible 
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reason is that these strains were propagated from a mixture of the correct 
recombinants and satellite colonies which can be located in the vicinity of the 
correct recombinant (Friedrich and Soriano, 1991). In addition, DNA methylation 
may alter the E2C expression level of the transfected mESCs. Different transgene 
expression patterns of Rosa26 targeting have been reported, implying complex 
genomic methylation levels in the generated strains that may result in gene 
silencing (Domínguez-Bendala and McWhir, 2004). Of note, the screened clone 
+D1 displayed an E2C-expression population of 87%, and moreover, showed a 
lower mean fluorescence intensity, suggesting that slight DNA methylation might 
have occurred and hence down-regulated the E2C level. Nevertheless, the reason 
for the varied expression levels in the Rosa26 targeted strains is still unclear.    
 
Many mESC lines have been established by viral transduction which results in 
random insertion of reporter genes into chromosomes leading to different gene 
copy numbers and integration sites. Although this approach can lead to higher 
expression levels due the presence of multiple copies of the transgene, the levels 
of expression can vary considerably between different cells within the transduced 
population. Furthermore, there is evidence that transgenes introduced into mESCs 
via viral transduction have a tendency to be silenced following differentiation to 
specific lineages (Lepperhof et al., 2014). Although targeted integration at the 
Rosa26 locus generally introduces only a single copy of the transgene into the 
Rosa26 allele (Friedrich and Soriano, 1991), leading to lower expression levels 
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that can be achieved with lentiviral transduction, there is a lower tendency for 
transgenes within the Rosa26 locus to become silenced following differentiation 
of the mESCs (Lepperhof et al., 2014). Therefore, this approach could be more 
suitable for tracking cells over the long-term.  
 
To summarise, in this chapter, we have generated a Bra-GFP/Rosa26-E2C mESC 
reporter line and have shown that these mESCs continue to express key stemness 
markers and retain the ability to differentiate. This line will be used in subsequent 
chapters to isolate nascent mesoderm following growth in 3-D as EBs and in 2-D 
differentiation culture, so that the properties of the mesoderm generated under 
these different culture conditions can be compared. 
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Chapter 4    
 
Evaluating the effectiveness of the E2-Crimson 
fluorescence reporter for tracking 
Bra-GFP/Rosa26-E2C mESCs in living mice 
                                                                   
 
4.1 Introduction  
The motivation for generating the Bra-GFP/Rosa26-E2C reporter mESC line 
(see Chapter 3) was to compare the behaviour and differentiation potential of 
mESC-derived Bra
+
 cells generated under different culture conditions, by 
monitoring their ability to give rise to renal cell types following (i) 
administration into adult mouse kidneys, and (ii) incorporation into mouse 
kidney rudiments ex vivo (chapter 6). However, given that fluorescence image 
of cells within the internal organs of mice can be challenging due to the 
aforementioned issues with autofluorescence, light absorbance and scattering 
(Chapter 1), it was first necessary to evaluate the effectiveness of E2C for 
tracking cells in vivo following subcutaneous administration in mice. It has 
previously been shown that if undifferentiated mESC are injected 
subcutaneously, they have a tendency to develop teratomas, which are benign 
tumours that typically contain cell types derived from more than one germ 
layer (Evans, 2011; Martin, 1981). Our strategy was therefore to assess 
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whether the presence of E2C in the cells would enable us to monitor teratoma 
formation in vivo with fluorescence imaging following implantation of the cells 
into the mouse flank. If the E2C reporter line was found to be effective for 
imaging the cells subcutaneously, we would then progress to monitoring the 
renal biodistribution and growth of the cells following systemic administration. 
However, if subcutaneous imaging proved difficult, this would suggest that the 
E2C would not be effective for detecting cells within the kidneys of mice in 
vivo. 
 
mESC-derived teratomas 
Although mESCs can contribute to embryo development following injection 
into mouse blastocysts, if they are injected into other locations such as 
retroperitoneum, they can generate non-invasive benign tumours called 
teratomas, or even malignant teratocarcinomas that resemble tumours formed 
by embryonal carcinomas and germ cells. Mature teratomas comprise 
well-differentiated tissues of the three germ layers, such as neural tissue, skin, 
hair, gland that are of ectoderm origin; adipose, smooth/skeletal/cardiac muscle, 
bone and cartilage that are of mesoderm origin; as well as gut and pancreas 
cells that are of endoderm origin (Nussbaum et al., 2007; Yamamoto, 2005; 
Martin, 1980; Stevens, 1970; Solter, 1970). It has also been shown that 
teratomas can be generated following subcutaneous injection of mESCs into 
adult mice (Martin, 1981; Wakitani et al., 2003). In some cases, additional 
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undifferentiated stem cells were found in the teratomas, contributing to the 
malignancy of progressive tumour growth and transplantation, but without 
metastasis. These teratomas were defined as teratocarcinomas (Martin, 1980). 
The maturity of the teratomas can be assessed at a histopathological level by 
their tissue components, particularly by the presence of neuroepithelium which 
emerges at an early immature stage (Wetherell et al., 2014). 
 
Experimental design 
Bra-GFP/Rosa26-E2C mESCs were injected subcutaneously into the dorsal 
flanks of female CB17 severe combined immunodeficient (SCID) mice using 
the following administration doses: 5×10
6
, 7.5×10
6
 and 10×10
6
. The control 
comprised untransfected E14-Bra-GFP mESCs which were injected at an 
administration does of 10×10
6
 cells. Following injection, fluorescence was 
detected in living mice using the IVIS Spectrum fluorescence imager on days 0, 
1, 4, 7 and 9. Tumour size was also measured at day 4, 7 and 9. On day 9, mice 
were sacrificed and tumours were fixed and paraffin embedded for 
histopathology, or frozen for immunohistochemical analyses. Details of 
protocols are described in Chapter 2.  
 
The specific objectives of this chapter were to: 
1. Quantify the intensity of the E2C fluorescence signal in vitro; 
2. Quantify the intensity of the E2C fluorescence signal in vivo over time; 
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3. Analyse the excised tumours at the study end-point using 
histopathology and immunofluorescence staining. 
 
4.2 Results 
4.2.1 Quantitative analysis of E2C fluorescence signal in vitro  
Prior to undertaking in vivo experiments, it was important to determine the 
signal intensity of the E2C fluorescence emitted by the newly-established 
mESC reporter line in order to establish the lower limits of detection. To this 
end, we assessed the fluorescence intensity of 2×10
6
 and 8×10
6
 E2C reporter 
cells in vitro by imaging cell pellets using the IVIS Spectrum. The results 
demonstrated that faint signals from 2×10
6
 and 8×10
6
 cell pellets were detected 
by IVIS, showing approximately 1.8- and 4-fold higher intensity than that of 
the background, respectively (Figure 4.1). This indicated that as expected, the 
level of E2C fluorescence increased within increasing cell number, but 
nevertheless, was relatively weak.   
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Figure 4.1 IVIS images of E2C
+
 mESC pellets comprising 2×10
6
 (A) and 8×10
6
 (B) 
cells compared to background (microfuge tube wall). Values of the region of 
interest (ROI) 1 were acquired from Bra-GFP/Rosa26-E2C mESC pellets. ROI 2 values 
were acquired from the background. Data are displayed in radiance units 
(p/sec/cm
2
/sr). 
 
4.2.2 Quantitative analysis of E2C fluorescence signal in vivo 
Bra-GFP/Rosa26-E2C mESCs suspended in PBS were injected 
subcutaneously in randomly selected sites in each mouse, at the following 
doses in an injection volume of 100 µL (5×10
6
, 7.5×10
6
 and 10×10
6
), along 
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with a control comprising 10×10
6
 untransfected mESCs. Palpable tumours 
were detected in each mouse from day 4. By day 7, several tumours developed 
reddish-blue discolouration, which was probably due to the high degree of 
vascularization (Figure 4.2).   
 
E2C fluorescence emitted from the reporter cell line in some injection sites was 
noticeable in vivo immediately following injection (Figure 4.3). In all 
experimental groups that were administered with Bra-GFP/Rosa26-E2C 
mESCs, the E2C decreased by 24 h post injection. Detectable fluorescence of 
E2C increased afterwards from this time-point and peaked on day 4. 
Surprisingly, although visual inspection suggested that the tumours were 
increasing in size, the E2C signal intensity decreased between days 4 and 9 but 
remained slightly higher than the control cells. However, there was no 
significant difference in fluorescence intensity in tumours generated by the 
reporter cells and untransfected cells (negative controls) within the 9-day 
growth period (Figure 4.4A).  
 
Quantitative analysis in terms of calculated mean region of interest (ROI) 
values showed that the E2C signal intensity emitted by the 10×10
6
, 7.5×10
6
 
and 5×10
6
 cell doses decreased from 2.3±0.3×10
8
, 2.2±0.5×10
8
, and 
1.9±0.2×10
8 
p/sec/cm2/sr, respectively, on day 0 to 1.5±0.3×10
8
, 1.5±0.3×10
8
, 
and 1.5±0.2×10
8 
p/sec/cm2/sr, respectively, on day 1. The signal then started to 
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increase and peaked at 2.9±1.0×10
8
, 2.8±0.4×10
8
, and 2.6±0.2×10
8
 
p/sec/cm2/sr, respectively, on day 4, before decreasing to 2.5±0.6×10
8
, 
2.8±0.3×10
8
, 2.4±0.3×10
8 
p/sec/cm2/sr, respectively, on day 9 (Figure 4.4A and 
Appendix Table 2). 
 
 
 
Figure 4.2 Growth of tumours from Bra-GFP/Rosa26-E2C mESCs in severe 
combined immunodeficient (SCID) mice that formed from 5×106, 7.5×106 and 10
×106 injected cells. The untransfected E14-Bra-GFP cells were used as a negative 
control (10×106 cells). A, mouse with tumours in 4 sites on day 9 post injection; B, 
dissected E2C tumour formed on day 9 post injection with 7.5×106 cells showing high 
degree of vascularisation. M represents million (×106). 
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To determine if the emitted fluorescence intensity correlated with tumour size, 
tumour volume was measured on days 4, 7 and 9. A mathematical model of 
solid tumour volume calculation has previously been constructed based on the 
assumption that tumours are hemi-ellipsoid in 3-D shape. Therefore, the 
volume is calculated from the measurements of tumour length, width and 
height using the following equation (Dethlefsen et al., 1968; Tomayko and 
Reynolds, 1989):  
 
𝑉 = π𝑙𝑤ℎ/6,                                                             (1)  
 
where V is the tumour volume, and l, w, h are the length, width, and height of 
tumour, respectively. 
 
Tumour growth curves were then constructed. The measurement data here 
displayed a distinct increase in tumour size during day 4 and 9.The increase in 
tumour volume for the 7.5×10
6
 dose of E2C reporter mESCs demonstrated an 
approximately 4-fold change compared to that of the 5×10
6
 cell dose. However, 
a noticeable increase in tumour volume was observed in all cases, irrespective 
of the administration dose (Figure 4.4B). Detailed data are shown in the 
Appendix Tables 1 and 2. 
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Figure 4.3 IVIS images in vivo at days 0, 1, 4, 7 and 9 post injection of E2C
+
 cells 
into the dorsal flanks of SCID mice. The emission filter of 605–660 nm wavelengths 
was applied to detect the fluorescent signal generated from Bra-GFP/Rosa26-E2C 
mESCs. The untransfected E14-Bra-GFP cells were used as negative controls. Data 
are displayed in radiance units (p/sec/cm
2
/sr). M represents million (×106). 
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Figure 4.4 Growth curves obtained based on the changes of mean region of 
interest (ROI) values and tumour volume post injection. (A) ROI values were 
generated by IVIS software for the time points of day 0, 1, 4, 7 and 9. (B) Tumour 
volume was calculated based on the manual measurements of tumours on day 4, 7 
and 9. Error bars represent ±SD (A) and ±SEM (B), respectively. (n=3). M represents 
million (×106). 
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4.2.3 Histopathology and immunofluorescence analyses of tumours  
At the study end point, the mESC tumours were harvested and paraffin sections 
were analyzed by a pathologist to confirm whether the tumours resembled 
teratomas. Analysis of H&E sections showed that the tumours resembled 
primitive germ cell tumours and immature teratomas, which typically contain 
neuroepithelial-like cells and other cell types such as chondrocytes (Figure 4.5). 
The tumours also appeared to be well-vascularised and contained abundant 
erythrocytes (Figure 4.5). 
 
To determine if all of the differentiated cells within the tumours continued to 
express E2C, and whether the tumour vasculature was derived from the mESCs 
or the host, immunofluorescence staining for E2C and the endothelial marker, 
PECAM-1, was undertaken. The results showed that most of the tumour cells, 
including the epithelial and chondrocyte-like cells, expressed E2C, indicating 
that the transgene expression was stable over this time-frame. As expected, 
there was no evidence of E2C expression in the control tumours (Figure 4.6). 
PECAM-1 staining showed that none of the endothelial cells within the tumour 
stained positively for E2C, indicating that they were all derived from the host 
(Figure 4.6). 
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Figure 4.5 Histological analysis of tumours derived from the mESCs. H&E 
staining was performed on paraffin sections prepared from the day-9 tumours. Arrow 
heads show epithelial structure (A–A’), thick arrows show chondrocyte-like cells (B–B’) 
and thin arrows show red blood cells (C–C’). Dashed lines show the structures of 
chondrogenic-like (mesoderm-like) differentiation (B-B’) and blood vessels (C–C’). 
Scale bars, 400 µm (A), 200 µm (B, C); 50 µm (A’–C’). 
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Figure 4.6 Immunostaining for E2C (red) and PECAM-1 (green) in tumours 
derived from E2C
+
 mESC reporters (E2C) or untransfected controls (Untft). Dual 
immunostaining of frozen sections prepared from tumours harvested at day 9 shows 
that all cells, except the vasculature and blood cells, within the tumours are derived 
from the E2C
+
 mESC, which stained positively for E2C. On the other hand, the 
endothelial cells within the tumours did not stain positively for E2C, indicating they 
were derived from the host animals. Tumours developed from the untransfected (untft) 
E14-Bra-GFP mESC were used as controls. Scale bar, 100 µm (all graphs). 
(continued on next page) 
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(continued from previous page) 
 
 
 
 
Figure 4.6, continued. 
 
 
4.3 Discussion 
In this chapter, to assess the feasibility of imaging the E2C mESC reporter cells 
in vivo using fluorescence imaging, we injected three cell doses subcutaneously 
into SCID mice and imaged over a 9-day time course.   
 
It was found that even when the animals were imaged immediately following 
cell administration, it was not always possible to detect the E2C signal. Thus, 
the main conclusion from this experiment is that the E2C is not an effective in 
vivo reporter in this context (i.e., when introduced as a single copy into the 
Rosa26 locus), and imaging the E2C reporters in the internal organs would not 
be feasible due to signal attenuation with increasing depth. In contrast to our 
findings, Christensen and colleagues were able to detectE2C emitted from 
tumour cells injected into the rat lung (Christensen et al., 2015). The likely 
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explanation is that they used lentiviral technology to generate the reporter cells, 
which would have introduced multiple copies of the E2C transgene into each 
cell. Furthermore, the E2C was expressed under the strong constitutive 
cytomegalovirus (CMV) promoter. 
 
In cases where the cells could be detected at day 0, it was found that E2C 
signal intensity decreased on day 1 before increasing between days 4 and 7. 
The reduction in signal at day 1 is probably due to cell death. SCID mice are 
deficient in generating T and B lymphocytes and thus are unable to launch an 
adaptive immune response. However, they still have an intact innate immune 
system, comprising neutrophils, macrophages and natural killer cells that might 
contribute to the death of injected mESCs (Bancroft et al., 1989). Another 
possible reason is that many of the mESCs may simply die due to the sudden 
change in their micro-environment, as it is well-known that these cells require 
specific culture conditions for their propagation. The increase in fluorescence 
observed in most tumours from days 4 to 7 probably reflected the fact that, 
over this time course, there was an increase in tumour volume. Interestingly, 
although the tumour volume continued to increase from days 4 to 7, in most 
cases, there was a decrease in fluorescence. This was most likely due to the fact 
that the tumours became highly vascularized. H&E staining of tumour sections 
showed a high number of red blood cells within the blood vessels. Since 
haemoglobin plays a major role in photon absorption within the <650 nm 
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wavelength region, it is likely that E2C fluorescence was partially absorbed by 
the red blood cells in the tumours (Weissleder, 2001).  
 
None of the mice injected with control untransfected mESCs were expected to 
display any E2C fluorescence signal. Of note, some background signal was 
observed in the control tumour of mouse number 3 on days 4 and 7 post 
injection. To confirm whether this was artifactual, or was due to migration of 
E2C
+ 
mESCs to the control injection site, immunostaining for E2C was 
performed on frozen sections of the control tumour. No evidence of E2C 
expression was observed, indicating that the signal observed with IVIS was 
artifactual background staining. This artifactual signal is likely due to photon 
scattering and autofluorescence from the skin abutting the tumour (Leblond et 
al., 2010). 
 
H&E histopathological examination of the tumours showed that they 
resembled immature teratomas, which typically have abundant neuroepithelial 
cells (Wetherell et al., 2014) as well as derivatives of other germ layers, such 
as chondrocytes (Shaaban et al., 2014). The abundant epithelial structures 
observed in the tumours are likely to resemble either primitive ectoderm 
epithelia or neuroepithelia. In the developing embryo, some of the primitive 
ectoderm cells that do not egress through the primitive streak directly give rise 
to neuroepithelial cells (LaBonne and Bronner-Fraser, 1999). Morphologically, 
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the primitive ectoderm and early neuroepithelial cells closely resemble each 
other. Chondrocyte-like cells were also present in the tumours, which would be 
consistent with them being immature teratomas. Endothelial cells were also 
identified lining blood vessels, but dual immunostaining for E2C and 
PECAM-1showed that these cells were derived from the host.  
 
There are numerous reports showing that following subcutaneous implantation 
or implantation under the kidney capsule, mESCs will typically form mature 
teratomas that contain various types of well-differentiated cells derived from 
the three germ layers, and can even generate endothelial cells which form part 
of the vasculature of the teratoma (Stevens, 1970). However, in these studies 
the teratomas were allowed to develop over a 4-week period instead of just 9 
days. Therefore, the fact that teratomas in this study were immature is probably 
due to the shorter time that they were allowed to develop in vivo.     
 
To summarise, the results obtained from imaging the reporter cells after 
subcutaneous implantation indicate that the emitted E2C fluorescence is weak 
and it would not be feasible to image the cells in internal organs such as the 
kidney. Therefore, the focus of the remaining chapters will be to compare the 
gene expression profile (Chapter 5) and the behaviour and differentiation 
potential of the different mESC-derived mesoderm populations in mouse 
embryo kidneys ex vivo (Chapter 6). 
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Chapter 5  
 
Characterisation of mesoderm derived from the 
Bra-GFP/Rosa26-E2C reporter mESCs cultured under 
3-D and 2-D conditions  
                                                                   
 
5.1 Introduction 
The next stage of this project aimed to generate nascent mesoderm cells from 
mESCs cultured under different culture conditions and compare their properties in 
regard to (i) expression of key genes (this chapter) and (ii) their behaviour and 
differentiation potential in the ex vivo mouse kidney rudiment model (chapter 6). 
For these characterization studies, the Bra-GFP/Rosa26-E2C reporter line was 
used so that FACS could be used to isolate Bra-GFP
+
 cells generated under the 
3-D and 2-D culture conditions. However, prior to this, it was necessary to first 
optimize the 3-D and 2-D systems and determine at which point the maximum 
levels of GFP
+
 (i.e., Bra
+
) cells are present within the populations. To facilitate 
this, for the 3-D EB culture conditions, GFP expression was continually 
monitored using a real-time fluorescence imager called ‘Cell-IQ’.  
 
Characterisation of Bra
+ 
cells: investigating the expression levels of 
lineage-specific genes  
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Following gastrulation, the Bra
+
 nascent mesoderm generates (i) paraxial 
mesoderm, which gives rise to the somites; (ii) lateral plate mesoderm, which 
gives rise to the heart, vessels, haematopoietic stem cells and endothelial cells; 
and (iii) intermediate mesoderm (IM), which gives rise to the urogenital system. 
The IM then becomes further specified to anterior IM (AIM) that gives rise to the 
ureteric bud (UB), and posterior IM (PIM) that gives rise to the metanephric 
mesenchyme (MM). The UB and MM generate the collecting ducts and nephrons, 
respectively, of the mature kidney (see chapter 6 Introduction). In the mouse 
embryo, the fate of the Bra
+
 cells is determined by the microenvironment that the 
cells find themselves in following their migration from the primitive streak 
(Gilbert, 2010). This cannot be replicated using in vitro culture systems, which 
raises the question of whether the Bra
+
 cells generated in vitro are equivalent to 
nascent mesoderm, or instead, are partially committed to a specific mesodermal 
lineage. For instance, the Little group have previously reported that BRA
+
 cells 
derived from human ESCs have a tendency to spontaneously differentiate into 
FOXF1
+
 lateral plate mesoderm when cultured in the absence of exogenous 
growth factors (Takasato, 2014). This observation highlights the fact that the 
differentiation potential of Bra
+
 cells generated in vitro is likely to be influenced 
by the specific culture conditions used. In this study, our aim was to investigate 
whether Bra
+
 cells generated using two different culture systems express different 
lineage genes, especially those expressed by specific mesoderm populations 
(Table 5.1). A brief overview of each of these genes is given below.  
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The T-box transcription factor gene, Tbx6, is expressed in the primitive streak, tail 
bud and paraxial mesoderm and plays a crucial role in mesoderm specification. 
Tbx6 mutations result in disruption of antero-posterior polarity (Papaioannou, 
2014; Chapman et al., 2003).  
 
Cdx2 is expressed in both the trophectoderm and the nascent mesoderm. Its 
expression pattern resembles that of Bra (Arnold et al., 2009; Taguchi et al., 2014; 
Savory et al., 2009). 
 
LIM-domain homeobox gene Lhx1 and odd-skipped-related gene Osr1 are 
expressed in lateral plate mesoderm at approximately E8.5. The expression of Osr1 
is observed alongside the antero-posterior axis from the first somite to the caudal 
region, overlapping the more posterior expression of Lhx1 which has an anterior 
boundary at the sixth somite (Dressler, 2009). In addition to being expressed in 
lateral plate mesoderm, Osr1 is also expressed in intermediate mesoderm and 
metanephric mesenchyme and plays an essential role in kidney development 
(James et al., 2006). 
 
The activation of Pax2 marks the specification of intermediate mesoderm (James 
and Schultheiss, 2005). Pax2 is expressed in the intermediate mesoderm and also in 
the metanephric mesenchyme (Dressler, 2009). 
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Hox genes encode a family of evolutionary conserved homeobox proteins (Hox) 
consisting of four clusters: Hoxa, b, c and d (Di-Poï et al., 2010). They play a role 
in somite specification along the antero-posterior axis of the mouse embryo 
(Mallo et al., 2010). Hoxb1 is one of the earliest Hox genes to be expressed 
(Kmita et al., 2000; Gadue et al., 2006). It was reported in the posterior primitive 
streak which can give rise to extraembryonic mesoderm (Tam and Loebel, 2007). 
Hox10 and Hox11 genes (Hoxa10, Hoxa11 and Hoxd11) are expressed not only in 
the posterior paraxial mesoderm but also in the metanephric mesenchyme, and are 
necessary for metanephros development (Carapuço et al., 2005; Yallowitz et al., 
2011). Hoxc9 was reported to be involved in the patterning of the sternum and ribs 
(Suemori et al., 1995); its expression was observed from E8.5 to E16.5 in 
posterior paraxial mesoderm derivatives, such as the prevertebrae and limb buds. 
It is also expressed in the developing kidney at E12.5 but the signal is weak 
(Erselius et al., 1990). Hoxd cluster genes are involved in limb-specific patterning 
(Kmita et al., 2000).  
 
The Fox-encoded forkhead box (Fox) family is another evolutionary conserved 
group of transcription factors (Jackson, 2010). In the mouse embryo, Foxf1 is 
expressed in posterior primitive streak-derived extraembryonic and lateral plate 
mesoderm at approximately E8.5 (Mahlapuu, 2001). Foxa2 expression represents 
the differentiation of anterior primitive streak (Gadue et al., 2006). Foxd1 is 
known for identifying the metanephric stromal cells following the divergent fate of  
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Table 5.1 Table of key genes investigated in this study 
Genes 
Expression 
Regions 
References Genes 
Expression 
Regions 
References 
Bra PS, TB, notocord 
a, b 
Foxa2 Anterior PS 
m 
Tbx6 PS, PM, TB 
a-c 
Foxd1 MM stroma 
n 
Cdx2 PS 
d-f 
Foxf1 PS, LPM 
0 
Lhx1 LPM, IM 
g 
Hoxa10 PM, MM 
e, p, q 
Osr1 LPM, IM, MM 
e, g 
Hoxa11 PM, MM 
e, p, q 
Pax2 IM, NC, MM 
g, h 
Hoxb1 Posterior PS 
m, r 
Wt1 IM, MM 
i 
Hoxc9 Posterior PM 
s 
Gdnf MM 
j-l 
Hoxd11 PM, MM 
p, q 
Notes: PS, primitive streak; PM, paraxial mesoderm; LPM, lateral plate mesoderm; IM, intermediate 
mesoderm; ND, nephric duct; MM, metanephric mesenchyme; TB, tailbud  
 
metanephric mesenchyme (Mugford et al., 2008). 
 
Gdnf is a member of the transforming growth factor beta (TGF-beta) family. It is 
expressed in the metanephric mesenchyme and induces the formation and 
branching of the ureteric bud, thus serving a critical role in nephrogenesis (Lin et 
al., 1993; Sanchez et al., 1996; Basson et al., 2006). 
 
Wt1 is expressed in the intermediate mesoderm, metanephric mesenchyme, 
nascent nephrons, but is restricted to the podocytes as the nephrons mature (Little, 
2015).  
a Papaioannou, 2014 h James et al., 2005 n Mugford et al., 2008 
b Herrmann et al., 1990 i Little, 2015 o Mahlapuu et al., 2001 
c Chapman et al., 2003 j Lin et al., 1993 r Kmita et al., 2000 
d Arnold et al., 2009  k Sanchez et al., 1996 s Erselius et al., 1990 
e Taguchi et al., 2014 l Basson et al., 2006 p Carapuço et al., 2005  
f Savory, et al., 2009 m Gadue et al., 2006 q Yallowitz et al., 2011 
g Dressler, 2009     
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Objectives 
The specific objectives of this chapter were to: 
1. Determine the optimal seeding density to generate typical (i.e., cavitating) 
embryoid bodies (EBs) from the Bra-GFP/Rosa26-E2C mESC reporter 
line; 
2. Investigate the expression profile of GFP in EBs derived from the 
Bra-GFP/Rosa26-E2C mESC reporter line using real-time imaging and 
determine the proportion of GFP
+
 cells within the population; 
3. Determine the proportion of GFP+ cells within the population following 
differentiation of the mESC reporter line to mesoderm using a 2-D culture 
system; 
4. Determine the FACS efficiency and the purity of GFP+ cells generated 
from Bra-GFP/Rosa26-E2C mESCs cultured under 3-D and 2-D 
differentiation conditions; 
5. Compare the expression profile of key genes in GFP+ mesodermal cells 
generated from Bra-GFP/Rosa26-E2C mESCs cultured under 3-D and 
2-D differentiation conditions.  
 
5.2 Results 
5.2.1 Optimisation of mESC seeding density for generating typical EBs  
It is known that mESC seeding density used to generate EBs can affect their size 
and differentiation potential (Koike et al., 2007). It was therefore important to 
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establish the optimal seeding density to promote the generation of typical EBs, 
that similar to the mouse embryo, generate extraembryonic endoderm, a basement 
membrane, a primitive ectoderm epithelium and a proamniotic-like cavity prior to 
undergoing a gastrulation-like process (see Chapter 1). It was also important to 
ensure that the introduction of E2C within the Rosa26 locus did not affect the 
ability of the E2C
+
 mESCs to form EBs, nor the ability of the mESCs to 
differentiate to Bra
+
 mesoderm. To do this, the Bra-GFP/Rosa26-E2C mESCs 
were plated at different densities (Table 5.2) and cultivated for 7 days in EB 
medium. At densities of 2.5×10
5
 and 1.25×10
5 
cells/mL, aggregates were observed 
during the first 24 h and cavitated EBs were apparent by day 4, with most EBs 
within the population having cavitated by day 7. However, at the lower seeding 
density of 6.25×10
4
 cells/mL, many EBs did not develop the typical EBs and 
failed to cavitate (Figure 5.1). 
 
Table 5.2 Optimisation of seeding density in EB culture system  
Cell line Densities (cells/mL) Time Points (Day) 
Bra-GFP/Rosa26-E2C 
6.25×10
4
 
4, 7 1.25×10
5
 
2.5×10
5
 
 
Mesoderm development was identified in all density conditions, but the 
expression patterns were different. At 6.25×10
4
 cells/mL, GFP was expressed at 
an earlier stage and peaked on day 4 before decreasing. In contrast, at higher 
densities, GFP became visible at day 4 or later and the fluorescence signal 
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increased from day 4 to 7, but there appeared to be more GFP
+
 cells in the 
1.25×10
5 
cells/mL EBs (Figure 5.1). Therefore, given that the EBs developing in 
the 1.25×10
5 
cells/mL density cultures appeared to be typical cavitating EBs that 
contained a high proportion of GFP
+
 cells, we used this plating density in all 
future experiments.  
 
 
 
 
Figure 5.1 Representative fluorescence and phase contrast photomicrographs of 
EBs derived from E2C mESC reporters at different seeding densities cultured for 7 
days. The majority of EBs derived from mESCs plated at densities of 2.5×10
5
 and 
1.25×10
5 
cells/mL showed evidence of cavitation, whereas cavitated EBs were less 
abundant in the lower density culture (6.25×10
4
 cells/mL). Maximal levels of GFP were 
observed in day 7 EBs derived from the 1.25×10
5 
density cultures. Data were collected 
from three biological replicates. Scale bars, 400 µm (top panel) and 100 µm (middle and 
bottom panels)   
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Figure 5.2 Immunostaining for E2C (red) in EBs derived from E2C mESC reporter 
line. Immunostaining of frozen sections of EBs harvested at day 7 showed that all cells 
within the EBs derived from the E2C mESCs stained positively for E2C, including the 
GFP
+
 mesodermal cells. Scale bar, 100 µm (all graphs).  
 
To investigate if E2C expression affected mesoderm differentiation, 
immunostaining of Bra-GFP/Rosa26-E2C EB sections was performed to confirm 
that the GFP
+
 cells within the EB expressed E2C. The results showed that all cells 
within the Bra-GFP/Rosa26-E2C EBs expressed E2C, including the GFP
+
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mesodermal cells, indicating that E2C expression did not inhibit mesoderm 
differentiation (Figure 5.2).  
 
5.2.2 Investigating the expression profile of GFP in EBs derived from the 
Bra-GFP/Rosa26-E2C mESC reporter line using real-time imaging 
and determining of the proportion of GFP
+
 cells within the population 
In order to accurately monitor changes in GFP expression in the developing EBs 
over time, Bra-GFP/Rosa26-E2C mESCs were plated at a density of 1.25×10
5
 
cells/mL and at day 3, were embedded in a sandwich-like agarose system (2% 
agarose bottom layer+EB+1% agarose overlay) and imaged in real-time using the 
Cell-IQ instrument every hour from day 3 to day 9 post plating. Data were 
collected from a total of 386 EBs. GFP started to be expressed on day 5, and 
reached maximum levels on day 6–7. Although expression levels began to 
decrease at this time point, GFP
+
 cells were still present at day 9 (Figure 5.3).  
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Figure 5.3 Representative fluorescence and phase contrast photomicrographs of 
EBs derived from Bra-GFP/Rosa26-E2C mESCs. Images were taken every hour. 386 
EBs were analysed. Scale bar, 200 µm (all graphs). 
 
To quantify the proportion of mesodermal cells within the EBs, flow cytometry 
analysis was performed. EBs derived from the wild-type E14TG2a mESCs were 
used as a negative control. The results were consistent with the Cell-IQ data, and 
showed that the peak GFP expression was day 6, at which time, approximately 39% 
of the EB population were GFP
+
 (Figure 5.4).  
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Figure 5.4 Flow cytometry analysis of disaggregated Bra-GFP/Rosa26-E2C EBs at 
different time points. Data showed that GFP started to be expressed on day 5, and 
reached maximum levels on day 6–7. At the peak of expression (day 6), GFP
+
 cells 
comprised 39% of the population. 
 
5.2.3 Determining the proportion of GFP+ cells within the population 
following differentiation of the mESC reporter line to mesoderm using 
a 2-D culture system 
To direct mesoderm differentiation using a 2-D culture system, we followed a 
method recently published by Turner et al, which involves culturing mESCs 
without feeders in serum free medium containing Activin and Chiron (Turner et 
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al., 2014a). To determine the efficiency of this culture system, the Bra- 
GFP/Rosa26-E2C mESCs were cultured under differentiation conditions for 4 
days, and were then screened for GFP expression. Analysis of fixed cells in 
culture showed that the vast majority of the population expressed GFP. Flow 
cytometry analysis showed that approximately 89% of the population was GFP
+
, 
which is consistent with the efficiency reported previously with this method 
(Figure 5.5).  
 
 
 
Figure 5.5 Analysis of GFP expression in Bra-GFP/Rosa26-E2C mESCs following 
directed differentiation to mesoderm using a 2-D culture system. (A) Following 
induction, cells no longer formed colonies, appeared differentiated, and the majority 
expressed GFP. (B) 4 days following growth under differentiation culture, flow cytometry 
analysis showed that ~89% of cells expressed GFP. Undifferentiated 
Bra-GFP/Rosa26-E2C mESCs sub-cultured in gelatinised dishes in mESC medium for 24 
h prior to induction were used as a negative control. Scale bar, 100 µm (all graphs). 
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5.2.4 Determining the FACS efficiency and the purity of GFP+ cells 
generated from Bra-GFP/Rosa26-E2C mESCs cultured under 3-D and 
2-D differentiation conditions 
Before comparing the expression levels of the key target genes in the GFP
+
 cells 
isolated from the 3-D and 2-D culture systems, it was first necessary to confirm 
that the GFP
+ 
cells isolated from each culture system were true mesodermal cells. 
 
Single cell suspensions from day-6 EBs and day-4 2-D monolayer cultures were 
generated. Both Bra-GFP
+
 and Bra-GFP
-
 populations from 3-D and 2-D systems 
were sorted. At the end of sorting, samples were re-analysed using the same 
parameters by defining a contamination portion (e.g. Bra-GFP
-
 cells) comprising 
less than 1% of the sorted populations (e.g. Bra-GFP
+
 cells), thus verifying the 
purity of individual groups. Results showed that sorting purity of GFP
+
 cells was 
over 94% (Figure 5.6), confirming they were pure populations.  
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Figure 5.6 Flow cytometry analysis of Bra-GFP
+
 populations sorted from 3-D (A) and 
2-D (B) systems using FACS. Day-6 EBs from E2C reporter mESCs were harvested for 
sorting (A2). Untransfected day-6 E14-Bra-GFP EBs were employed as the negative 
control (A1). For 2-D, E2C reporter mESCs induced for 48 h were harvested (B2). E2C 
reporter mESCs maintained undifferentiated in gelatinised dishes in mESC medium for 24 
h prior to induction were employed as the negative control (B1). All of the sorted cells 
using flow cytometry to confirm the purity of the populations isolated using FACS (A3–4, 
B3–4). 
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5.2.5 Comparing the expression profile of key genes between the GFP+ 
mesodermal cells generated from the Bra-GFP/Rosa26-E2C mESC 
reporter line cultured under 3-D and 2-D differentiation conditions 
In order to characterize the Bra-GFP
+
 and Bra-GFP
-
 populations, RT-qPCR was 
performed to examine the expression patterns of key genes of mesodermal 
lineages and of early kidney development. Relative gene expression levels were 
evaluated and compared between the following groups: (i) the Bra-GFP
+
 and 
Bra-GFP
-
 populations isolated from the EBs (3-D system); (ii) Bra-GFP
+
 and 
Bra-GFP
-
 populations isolated from the 2-D system; and (iii) the Bra-GFP
+
 
populations isolated from the 3-D and 2-D systems. Stemness markers Oct4 and 
Nanog and the primitive ectoderm marker, Fgf5, were also evaluated to assess 
whether the undifferentiated mESCs and/or ectoderm cells were present.    
   
Firstly, comparisons were made between the key gene expression levels in the 
Bra-GFP
+
 cells and the Bra-GFP
-
 cells isolated from the 3-D and 2-D system, 
respectively. The results showed that the early mesoderm genes Bra, Cdx2, Tbx6, 
Foxf1, Foxa2, Hoxb1 and Hoxc9 were expressed by Bra-GFP
+
 cells isolated from 
both the 3-D and 2-D systems, but the relative expression levels differed in 
comparison to the respective Bra-GFP
-
 populations. For instance, under the 3-D 
conditions, the expression levels of Bra, Cdx2, Tbx6, Foxf1, and Hoxb1 in the 
Bra-GFP
+
 population were approximately 55-, 10- , 40-, 10- and 55-fold higher 
than in the Bra-GFP
-
 population, respectively, whereas under the 2-D conditions, 
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Bra, Tbx6 and Hoxb1 levels in the Bra-GFP
+
 cells were only respectively 2-, 4-, 
and 5-fold higher than in the Bra-GFP
-
 cells (Figure 5.7A, C).    
 
There was a 1- to 10-fold up-regulation of Hox10 and Hox11 paralogy groups 
(Hoxa10, Hoxa11 and Hoxd11) in the Bra-GFP
+
 population compared to the 
Bra-GFP
-
 population isolated from cells under 3-D conditions. In contrast, 
down-regulation of the same genes was observed in the Bra-GFP
+
 population 
isolated from cells under 2-D conditions compared to the Bra-GFP
-
 population 
(Figure 5.7A, C). This suggested that the status of Bra-GFP
+
 cells isolated from 
EBs may be closer to a stage resembling posterior mesoderm, as it has been 
shown previously that posterior mesoderm, which gives rise to the MM, expresses 
higher levels of Hox10 and 11 genes compared to anterior mesoderm (Taguchi et 
al., 2014). 
 
Genes of intermediate mesoderm and metanephric mesenchyme, i.e., Lhx1, Osr1, 
Pax2 and Wt1, displayed a similar trend in the change of relative expression levels 
between the Bra-GFP
+
 and Bra-GFP
-
 groups under 3-D and 2-D conditions. It is 
of note that in the cells isolated from the EBs, Lhx1 was up-regulated by 
approximately 10-fold in the Bra-GFP
+
 cells compared to the Bra-GFP
- 
cells, 
whereas there was minimal up-regulation in the Bra-GFP
+
 cells isolated from the 
2-D conditions (Figure 5.7A, C). 
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Figure 5.7 Expression levels of mesoderm and early kidney development key genes 
in the FACS-sorted Bra-GFP
+
 and Bra-GFP
-
 populations isolated from 3-D and 2-D 
systems. Relative expression levels were compared between Bra-GFP
+
 and Bra-GFP
-
 
populations isolated from 3-D system (A–B, n=2), 2-D system (C–D, n=2). Error bars 
represent the range of value change. 
(continued on next page) 
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(continued from previous page) 
 
 
 
Figure 5.7, continued. 
 
Oct4, Nanog and Fgf5 were also evaluated and the data showed no difference 
between the Bra-GFP
+
 cells and Bra-GFP
-
 cells isolated from both 3-D and 2-D 
conditions (Figure 5.7B, D). 
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Next, the relative expression levels of the various genes in Bra-GFP
+
 cells isolated 
from 3-D and 2-D system was compared.  
 
 
 
Figure 5.8 Expression levels of mesoderm and early kidney development key genes 
in the FACS-sorted Bra-GFP
+
 populations isolated from 3-D and 2-D systems. 
Relative expression levels were compared between Bra-GFP
+
 populations isolated from 
3-D system (A, n=3) and 2-D system (B, n=3). Error bars represent ±SEM. p<0.05 
(asterisks) was considered as statistically significant (t-test). 
 
There was no significant difference in the expression levels of Bra and Tbx6, 
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whereas Cdx2, Foxf1 and Hoxb1 were significantly up-regulated by 9-, 30-, 5-fold, 
respectively, in the Bra-GFP
+
 cells isolated under 3-D conditions. Another early 
mesoderm gene Hoxc9 as well as posterior mesoderm genes Hox10 and Hox11 
were also up-regulated but not significantly. The expression levels of Lhx1, Osr1, 
Pax2, Wt1 and Gdnf were comparable between the two populations. On the other 
hand, Foxd1, which, is expressed in MM and stroma, showed a slight 2-fold 
up-regulation in the 3-D Bra-GFP
+
 cells (Figure 5.8).    
 
5.3 Discussion 
In this chapter, mesoderm populations were generated from a 
Bra-GFP/Rosa26-E2C mESC reporter line using 3-D and 2-D differentiation 
conditions. Bra-GFP
+
 cells were acquired following the optimisation and 
evaluation of the culture systems. The expression levels of key genes of 
mesoderm and early kidney development were then analysed using quantitative 
RT-PCR. 
 
The dynamics of GFP expression during EB culture was similar to what has been 
previously observed in our group (Rak-Raszewska, 2010); i.e., at low seeding 
density, GFP appeared to peak earlier than at higher seeding densities. A possible 
explanation is that mESCs might express inhibitors of mesoderm differentiation, 
such as noggin, which would be present at higher levels in higher density cultures, 
and might therefore delay mesoderm differentiation (GFP expression) (Gratsch 
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and O'Shea, 2002; Tonegawa and Takahashi, 1998). Also, GFP expression was 
detected in EBs generated at low density that had not cavitated. This is similar to 
our lab’s previous findings using the same E14-Bra-GFP mESC line 
(Rak-Raszewska, 2010). In that study, GFP was only expressed within the EBs 
during days 3 to 4 with about 60% of the population expressing GFP at day 4 
(Rak-Raszewska, 2010). This is much higher than the proportion we observed in 
the current study (less than 40%). However, EBs generated using Fehling’s 
method did not form a proamniotic-like cavity, extra-embryonic endoderm or 
basement membranes. It is therefore envisaged that the properties of Bra
+
 
mesoderm cells generated from the two types of EBs (i.e., cavitating or 
non-cavitating), might have different properties and differentiation potential.  
 
An interesting finding from the RT-qPCR analysis was that the expression levels 
of Bra in the GFP
+
 cells isolated from the 3-D system were approximately 50 
times higher than in the GFP
-
 cells, but Bra levels in GFP
+
 cells isolated from the 
2-D system were only approximately three times higher than in the corresponding 
GFP
-
 cells. Yet despite this, when Bra levels in the GFP
+ 
cells from the 3-D 
system were directly compared with levels in GFP
+
 cells from the 2-D system, 
there was no significant difference. A possible explanation for this is that the GFP
-
 
cells in the EBs are likely to be endoderm or ectoderm cells that do not express 
Bra, whereas in the 2-D system, it is possible that the GFP
-
 cells might be 
committed to the mesodermal lineage and have started to up-regulate Bra, but due 
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to the time-lag between transcription and translation, might not have yet started to 
produce GFP. If this were the case, such cells would be Bra
+
 but GFP
-
, and would 
thus have been sorted into the GFP-negative fraction by FACS. 
 
When comparing the expression levels of key genes between the GFP
+
 cells from 
the 3-D and 2-D systems, there were only three genes that were significantly 
up-regulated in the cells from 3-D system, namely, Foxf1, Cdx2 and Hoxb1. The 
high expression levels of Foxf1 might suggest that the GFP
+
 cells from the 3-D 
system might be lateral plate mesoderm cells. It is known that high levels of 
BMPs promote the differentiation of lateral plate mesoderm, whereas low levels 
of BMPs promote intermediate mesoderm (Tonegawa and Takahashi, 1998). It is 
therefore possible that in the larger cavitating EBs, there might be higher levels of 
BMPs which would then drive the differentiation of lateral plate mesoderm. 
However, the cells also had significantly higher levels of the nascent mesoderm 
gene, Cdx2, and the posterior mesoderm gene, Hoxb1. Furthermore, although not 
significant, there was a clear trend that the Hox genes tested, which are expressed 
in intermediate mesoderm, were up-regulated in the cells from the 3-D system. 
 
In summary, it can be seen that the expression profiles of some key mesodermal 
lineage genes are different depending on whether the cells are derived from the 
3-D and 2-D culture systems, and are also different from GFP
+
 cells isolated 
previously in our lab from non-cavitating EBs, which expressed very low levels of 
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Foxf1 (Rak-Raszewska, 2010). In the next chapter, the differentiation potential of 
the cells will be tested by incorporating them into mouse kidney rudiments ex 
vivo. 
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Chapter 6  
 
Evaluation of the nephrogenic potential of the mesoderm 
derived from the Bra-GFP/Rosa26-E2C reporter mESCs 
cultured under the 3-D and 2-D conditions 
                                                                   
 
6.1 Introduction 
Mammalian kidney development 
Mouse kidney development begins at approximately E8.0 when the intermediate 
mesoderm gives rise to a pair of nephric ducts which extend along the rostro- 
caudal axis towards the cloaca (Grote et al., 2006; Pedersen et al., 2005). It 
generates three types of excretory organs in a sequential order: the pronephros, the 
mesonephros and the metanephros. The pronephros form at E8.5 but degenerate 
by apoptosis (Bouchard et al., 2002; Saxén, 1987). The mesonephros arises 
caudally to the pronephros at around E9.5, but is also transient in mammals and 
birds (Sainio and Raatikainen-Ahokas, 1999; Saxén, 1987; Tilmann and Capel, 
2002). At around E10.5, a region of the intermediate mesoderm at the level of the 
hindlimb condenses to form the metanephric mesenchyme (MM). The MM cells 
secrete glial cell-derived neurotrophic factor (Gdnf) that induces outgrowth of the 
ureteric bud (UB) from the nephric duct (Sainio et al., 1997; Hellmich et al., 
1996). The UB extends into the MM, giving rise to the metanephros (Figure 6.1) 
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(Saxén, 1987; Costantini and Kopan, 2010). 
 
 
 
 
Figure 6.1 Schematic diagram of mouse kidney development from E9.0 to E11.5. 
 
Reciprocal inductive interactions between the UB and the MM lead to repetitive 
branching of the UB in the MM that respectively develops into the nephrons and 
collecting duct network of the mature kidney. From E11.5, the MM condenses 
around the tip of the UBs to form the cap mesenchyme, the progenitor of the 
nephrons. The MM also gives rise to the kidney stroma. As the UB branches, renal 
vesicles form from the cap mesenchyme and further generate an epithelial 
structure called the S-shaped body. The proximal region of the S-shaped body is 
infiltrated by endothelial cells which develop into a capillary network called the 
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glomerular tuft. The glomerular tuft comprises afferent and efferent capillaries, 
the former of which have a larger diameter, thus creating increased pressure 
within the glomerulus which contributes to glomerular filtration and urine 
formation. The remaining compartments of the S-shaped body differentiate into 
proximal and distal tubules of the nephron. The proximal tubules elongate towards 
the medulla and form Henle’s loop which is connected to the distal tubules 
(Figure 6.2) (Dressler, 2009; Rak-Raszewska et al., 2015).  
 
The mechanisms of how the intermediate mesoderm becomes specified as MM 
and the nephric duct (which gives rise to the UB) are not yet completely defined. 
It was thought that both the MM and UB were derived from Osr1
+ 
anterior 
intermediate mesoderm (Mugford et al., 2008). However, recent work from 
Nishinakamura’s group has shown that while the UB and mesonephros are 
generated from anterior intermediate mesoderm, the MM is derived from Bra
+
 
posterior mesoderm. This Bra
+
/Osr1
-
 posterior mesoderm population gives rise to 
Bra
-
/Osr1
+
 posterior intermediate mesoderm that expresses Wt1 and Hox11, 
which gives rise to the MM, which expresses Pax2 and Six2 (Taguchi et al., 
2014). 
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Figure 6.2 Schematic illustration of the early development of metanephric 
mesenchyme (MM) and ureteric bud (UB) during mouse nephrogenesis. (A) The MM 
condenses around UBs at E11.5 forming the cap mesenchyme (CapM), while the 
remaining MM gives rise to the kidney stroma. (B) UBs branch upon reciprocal interaction 
between themselves and the MM. Renal vesicles (RV) form from the CapM giving rise to 
the S-shaped body (SB). The SB is infiltrated by endothelial cells which give rise to the 
glomerular (G) capillary tuft with afferent and efferent arterioles (A). The SB generates all 
parts of the nephron, including the glomerulus, proximal and distal tubules (PTs, DTs) and 
Henle’s loop (HL). 
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Testing the nephrogenic potential of stem and progenitor cells 
In order to test whether specific types of stem and progenitor cells are able to 
generate cells of the nephron or UB, our group has previously used an ex vivo 
kidney rudiment culture system developed by the Davies lab (Unbekandt and 
Davies, 2010). In this system, mouse kidney rudiments are disaggregated to a 
single cell suspension, mixed with the cell type being tested and centrifuged to 
promote reaggregation. The chimeric pellet is then cultured on a specific filter 
membrane at the air–medium interface and the fate of the test cells investigated 
(Figure 6.3) (Rak-Raszewska et al., 2012a; Kuzma-Kuzniarska et al., 2012; 
Ranghini et al., 2013; Dauleh et al., 2016). Re-aggregated metanephric cells are 
able to generate nephrons and UBs that appear to undergo the same reciprocal 
inductive events that occur in intact rudiments, except that there is no longer a 
contiguous ureteric bud tree. It should also be noted that similarly to intact 
rudiments, re-aggregated rudiments contain endothelial cells (Halt et al., 2016). It 
was previously thought that endothelial cells rapidly degenerated in kidney 
rudiments cultured ex vivo (Loughna et al., 1997), but more recent studies show 
that endothelial cells are retained and can form networks. However, the 
endothelial cells do not form typical capillaries with lumen and they do not 
generate a capillary tuft as they do in vivo (Halt et al., 2016).   
 
To investigate the fate of any exogenous test cells within chimeric kidney 
rudiments, it is necessary to introduce a label that enables the cells to be 
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distinguished from the metanephric cells. Our group has previously labelled the 
stem or progenitor cells under test with quantum dots (Rak-Raszewska et al., 
2012a and 2012b; Ranghini et al., 2013). However, a disadvantage of quantum 
dots is that, unlike genetic reporters, they are diluted with each cell division and 
therefore do not permanently label the cells and their progeny.  
 
Our group has previously used ex vivo chimeric kidney rudiments to investigate 
the nephrogenic potential of Bra
+
 mesodermal cells isolated from E14-Bra-GFP 
mESC-derived EBs (Rak-Raszewska et al., 2012a). This study showed that the 
Bra
+
 cells could integrate into the developing rudiment and generate functioning 
proximal tubule cells, podocytes and ureteric bud cells. However, the EBs that 
were generated in this study were atypical, in that they did not form 
extraembryonic endodermal cells on their periphery, nor did they form a columnar 
layer of primitive ectoderm or a proamniotic-like cavity. In the current study, we 
wished to investigate the nephrogenic potential of Bra
+
 cells derived from typical 
EBs that more closely resemble the early embryo, in that they form 
extraembryonic endoderm, primitive ectoderm and a proamniotic-like cavity (see 
Chapter 1). We found in Chapter 5 that, in contrast to atypical EBs where GFP 
was maximal at day 3−4, GFP expression in the more typical cavitating EBs 
tended to be expressed later and persist for longer. This led us to hypothesise that 
GFP
+
 cells isolated from the later time points of typical EBs (i.e., day 6) might 
resemble the posterior mesoderm that gives rise to the MM. If this were the case, 
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we would expect that these GFP
+
 cells would only generate MM derivatives and 
would not integrate into UBs. A further aim of the current study was to assess the 
nephrogenic potential of Bra
+
 cells generated from a recently-developed 2-D 
differentiation system, in order to assess whether their differentiation potential 
was equivalent to the Bra
+
 cells generated from the typical EBs. 
 
 
 
Figure 6.3 Schematic illustration of the method for generating chimeric rudiments 
ex vivo culture. E13.5 embryonic kidneys were dissected (A, bright field). Rudiments 
were isolated and enzymatically dissociated to form a single cell suspension (B). GFP+ 
cells were isolated using FACS from either 3-D or 2-D culture systems and were mixed 
with the dissociated rudiment cells (C) and pelleted (D). The pellets were transferred onto 
a filter membrane and cultured at the air–medium interface (E). Scale bar, 50 µm.  
 
Experimental design 
E13.5 CD1 mouse kidney rudiments were dissociated and Bra-GFP
+
 cells sorted 
from either 3-D or 2-D culture systems of the Bra-GFP/Rosa26-E2C reporter 
mESCs. Bra-GFP
+
 and rudiment cells were mixed at a ratio of 1:9 and centrifuged 
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to acquire chimeric pellets, each of which comprised 2×10
5
 cells. Positive control 
chimeras comprised GFP
+
 mouse neonatal kidney-derived stem cells instead of 
the Bra-GFP
+
 cells, as the former have previously been shown to integrate into 
developing nephrons and generate podocytes and proximal tubule cells (Ranghini 
et al., 2013) A further control comprised non-chimeric re-aggregated rudiments 
that did not contain any additional cell types. Pellets were analysed on day 0 and 
day 5. Intact E13.5 rudiments cultured ex vivo for 5 days served as a control for 
the various immunostainings. Details of protocols are described in Chapter 2. 
 
Objectives 
The specific objectives of this chapter were to: 
1. Establish the staining pattern of key genes of renal development using 
intact mouse kidney rudiments cultured ex vivo;  
2. Confirm that re-aggregated non-chimeric mouse kidney rudiments 
cultured ex vivo develop similarly to intact rudiments; 
3. Confirm that positive control chimeric kidney rudiments comprising 
mouse kidney-derived stem cells develop similarly to intact rudiments; 
4. Investigate the behaviour of the two different types of mESC-derived 
Bra-GFP
+
 cells within the chimeric kidney rudiments cultured ex vivo. 
 
6.2 Results 
6.2.1 Ex vivo development of intact kidney rudiments  
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In order to evaluate how the Bra-GFP
+
 cells behave in the rudiment culture, it was 
first necessary to establish the typical staining pattern of various renal 
cell-specific antibodies in intact kidney rudiments cultured ex vivo. Following 5 
days of ex vivo culture, the rudiments were fixed and immunofluorescence was 
performed to detect the following markers: megalin, which is expressed on the 
apical surfaces of proximal tubule cells; Wt1, which is expressed in MM and 
developing nephrons, and expressed at very high levels in nascent and mature 
podocytes (Ranghini et al., 2013; Taguchi et al;., 2014); synaptopodin, which is 
expressed in mature podocytes. The rudiments were also stained with 
rhodamine-labeled peanut agglutinin (PNA), which mainly binds to the basement 
membranes of ureteric buds, and more weakly to those of the developing 
nephrons (Laitinen et al., 1987). PNA staining showed an intact ureteric bud tree 
and immunostaining for megalin showed typical staining of the apical surfaces of 
proximal tubule cells (Figure 6.4). As expected, immunostaining for Wt1 showed 
weaker expression in MM and developing nephrons and intense expression in 
nascent and mature podocytes, whereas synaptopodin was exclusively expressed 
in mature podocytes (Figure 6.4).   
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Figure 6.4 Confocal photomicrographs of intact kidney rudiments cultured ex vivo 
for 5 days. Proximal tubules were positively stained for megalin (Meg, green) and PNA 
(red). Developing glomeruli were immunostained for Wt1 (green) and synaptopodin 
(Synap, green) positive staining. Arrows point to developing podocytes and arrowheads 
point to MM. Scale bars, 200 µm (A−C) and 100 µm (A’−C’). 
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6.2.2 Ex vivo development of re-aggregated non-chimeric mouse kidney 
rudiments  
To confirm that re-aggregated kidney rudiments could develop nephron and 
ureteric bud structures as previously reported (Ranghini et al., 2013; Rak- 
Raszewska et al., 2011), dissociated kidney rudiment cells were pelleted and 
cultured ex vivo prior to staining with the aforementioned markers. Firstly, it was 
important to confirm that the disaggregation process was effective and that no 
non-dissociated renal structures were present at the start of the culture period. 
Therefore, at day 0, rudiments were stained for megalin and PNA. The results 
showed that no staining was present at day 0, whereas multiple tubular structures 
were present by day 5 (Figure 6.5). 
   
 
 
Figure 6.5 Confocal photomicrographs of the re-aggregated non-chimeric 
rudiments cultured ex vivo at day 0 (A) and 5 (B−C). Tubule-like structures formed 
during the 5-day culture. Meg, megalin (green). Boxed regions outlined are enlarged in the 
magnified image. Scale bar, 200 µm (A−B) and 50 µm (C). 
 
More detailed analysis of the re-aggregated rudiments showed that the number of 
tubular structures and nascent glomeruli appeared similar to that of the intact 
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rudiments, but consistent with previous studies (Ranghini et al., 2013; 
Rak-Raszewska et al., 2012a; Kuzma-Kuzniarska et al., 2012), although ureteric 
bud tubules formed, they did not form a contiguous ureteric bud tree (Figure 6.6). 
 
 
 
 
Figure 6.6 Confocal photomicrographs of the re-aggregated non-chimeric 
rudiments cultured ex vivo for 5 days. The re-aggregated rudiments contain tubules 
and nascent glomerular-like structures that are similar to those of the intact rudiments 
cultured for 5 days. Meg, megalin (green); Synap, synaptopodin (green). Boxed regions 
outlined are enlarged in the magnified images. Scale bars, 200 µm (A−B) and 50 µm 
(A’−B’). 
 
6.2.3 Ex vivo development of re-aggregated chimeric mouse kidney 
rudiments comprising mouse kidney-derived stem cells  
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Before assessing the nephrogenic potential of the mESC-derived Bra
+
 cells in the 
chimeric rudiment assay, it was first necessary to confirm that chimeric rudiments 
comprising a positive control cell population developed as expected. To this end, 
chimeric rudiments containing GFP
+
 mouse neonatal kidney-derived stem cells 
(mKSCs) were generated, as we have previously shown that mKSCs can generate 
proximal tubule cells and podocytes within rudiments (Ranghini et al., 2013). The 
chimeric rudiments were cultured for 5 days ex vivo and analysed as previously 
using the renal cell-specific markers. 
 
 
 
 
Figure 6.7 Confocal photomicrographs of the re-aggregated pellets at day 0 
containing no exogenous cells or GFP
+
 mKSCs Positive control GFP+ mKSCs showed 
even distribution represented by GFP (green) in the pellets at the beginning of the 
rudiment culture. Scale bar, 200 µm for all images. 
 
On day 0, the mKSCs were evenly distributed in the chimeric rudiments (Figure 
6.7). After 5 days of culture, the chimeric rudiments had developed megalin
 
positively-stained proximal tubules as well as nascent glomeruli that contained 
podocytes, as evidenced by the presence of positive staining for Wt1 and 
synaptopodin. mKSCs showed integration into the tubules and glomeruli of the 
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developing nephrons (Figure 6.8). 
 
 
 
Figure 6.8 Confocal photomicrographs of the GFP
+
 mKSC chimeric rudiments 
cultured ex vivo for 5 days. mKSCs (green) showed integration into the tubules and 
glomeruli of the developing nephrons. Arrows point to the integrated KSCs that were 
GFP-labelled and dual stained by PNA (red), megalin (Meg, blue), Wt1 (blue) or 
synaptopodin (Synap, blue). Boxed regions outlined in white are represented as the 
enlargements of the main image frame. Scale bars, 200 µm (A−C) and 50 µm (A’−C’). 
(continued on next page) 
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 (continued from previous page) 
 
 
 
Figure 6.8, continued. 
 
6.2.4 The behaviour of mESC-derived Bra-GFP+ cells within chimeric 
kidney rudiments cultured ex vivo 
Firstly, the behaviour of E2-Crimson-expressing (E2C
+
) Bra-GFP
+ 
cells isolated 
from mESC-derived EBs (3-D culture system) were investigated in the ex vivo 
rudiment assay. Staining for PNA, megalin, Wt1 and synaptopodin showed that 
similarly to the positive control chimeras comprising mKSCs, the re-aggregated 
metanephric cells were able to develop tubular structures and nascent glomeruli 
(Figure 6.9). However, immunostaining for E2C showed that the EB-derived cells 
did not integrate into tubules or glomeruli, and instead, appeared to elongate and 
form interconnected cell networks throughout the rudiment. In many cases, the 
EB-derived cells appeared to align against the outer surface of developing 
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glomeruli (Figure 6.9). 
 
 
 
Figure 6.9 Confocal photomicrographs of the day-5 chimeric rudiments comprising 
Bra-GFP
+
 cells derived from mESC 3-D system. E2C
+
 Bra-GFP
+
 cells (blue) appeared 
to be elongated and formed an interconnected network within the rudiments. They were 
often found surrounding the tubules (red) and glomerular structures (green) but did not 
integrate into them. Meg, megalin (green); Synap, synaptopodin (green). Boxed regions 
outlined are enlarged in the magnified images. Scale bars, 200 µm (A−C) and 50 µm 
(A’−C’). 
(continued on next page) 
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(continued from previous page) 
 
 
 
Figure 6.9, continued. 
 
Next, the behaviour of E2C
+
 Bra-GFP
+ 
cells isolated from the 2-D culture system 
was investigated using the chimeric rudiment assay. As with the EB-derived 
Bra-GFP
+ 
chimeras, staining for PNA, megalin, Wt1 and synaptopodin showed 
that re-aggregated metanephric cells in chimeras comprising Bra-GFP
+ 
cells 
isolated from the 2-D culture system were able to generate tubular structures and 
nascent glomeruli (Figure. 6.10). Similarly to the E2C
+
 EB-derived Bra-GFP
+ 
cells, the cells isolated from the 2-D culture system did not appear to integrate 
into tubules or glomeruli. However, in contrast to the EB-derived cells, those 
isolated from 2-D culture tended not to form connections with each other. 
Although elongated cells were occasionally observed in close proximity to 
developing glomeruli, the majority of the cells were not elongated and did not 
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from interconnected cell networks (Figure 6.10). Furthermore, there appeared to 
be fewer E2C cells present in these chimeras compared to those generated from 
mESC-derived Bra-GFP
+
 isolated from EBs. 
 
 
 
Figure 6.10 Confocal photomicrographs of the day-5 chimeric rudiments 
comprising Bra-GFP
+
 cells isolated from mESC 2-D system. Less Bra-GFP
+
 cells 
(blue) were observed with limited connections. However, they showed a peripheral 
distribution similar to the pattern in the day-5 chimeric rudiments with 3-D derived 
Bra-GFP
+
 cells. Meg, megalin (green); Synap, synaptopodin (green). Boxed regions 
outlined are enlarged in the magnified images. Scale bars, 200 µm (A−C) and 50 µm 
(A’−C’).                                                  (continued on next page) 
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(continued from previous page) 
 
 
 
Figure 6.10, continued. 
 
The morphology of E2C
+
 Bra-GFP
+
 cells within the chimeras generated from 
EB-isolated cells appeared similar to that of endothelial cells within ex vivo 
kidney rudiments (Halt et al., 2016). To investigate if the E2C
+ 
cells had 
differentiated into endothelial cells, the rudiments were immunostained for the 
endothelial marker, PECAM-1 (platelet and endothelial cell adhesion molecule 1) 
(Kondo et al., 2007). It was found that the metanephric cells generated 
PECAM-1
+
 interconnected cell networks in both types of chimeric rudiment, 
indicating that endothelial cells had differentiated. Analysis of E2C
+
 cells within 
the chimeric rudiments generated from EB-derived Bra-GFP
+
 cells showed that 
the majority of these cells appeared to stain positively for PECAM-1, suggesting 
that they had differentiated into endothelial cells. In contrast, most of the E2C
+
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cells within the chimeric rudiments generated from 2-D culture-derived Bra-GFP
+
 
cells did not stain positively for PECAM-1. Instead, only the elongated cells 
which were occasionally observed within these chimeras were found to stain for 
PECAM-1 (Figure 6.11). 
 
 
 
Figure 6.11 Confocal photomicrographs showing PECAM-1 immunostaining within 
Bra-GFP
+
 chimeric rudiments. Immunostaining for E2C was undertaken to identify the 
mesodermal cells and PECAM-1 immunostaining was performed to identify 
endothelial-like cells. A−A’, re-aggregated non-chimeric rudiments; B−B’, re-aggregated 
chimeric rudiments containing E2C
+
 Bra-GFP
+
 cells isolated from the 3-D culture system; 
C−C’, re-aggregated chimeric rudiments containing E2C
+
 Bra-GFP
+
 cells isolated from the 
2-D culture system. Boxed regions outlined are enlarged in the magnified images. Scale 
bars, 200 µm (A−C) and 50 µm (A’−C’). 
(continued on next page) 
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(continued from previous page) 
 
 
 
Figure 6.11, continued. 
  
6.3 Discussion 
In this chapter, by introducing the E2C-lablled mesodermal cells into the chimeric 
rudiments ex vivo, we showed that neither the Bra-GFP
+
 cells derived from the 
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3-D nor 2-D culture systems appeared to integrate into the developing nephrons. 
The results are strikingly differed from our lab’s previous studies that investigated 
the nephrogenic potential of mKSCs and Bra-GFP
+
 cells isolated from non- 
cavitating EBs in the same rudiment culture assay (Ranghini et al., 2013; 
Rak-Raszewska et al., 2012a). In these earlier studies, it was found that mKSCs 
could integrate into developing nephrons and generate proximal tubule cells and 
podocytes, but did not integrate into the ureteric bud (Ranghini et al., 2013). The 
Bra-GFP
+
 mESCs derived from non-cavitating EBs were able to integrate into 
both the developing nephrons and ureteric buds, and could form functional 
proximal tubule cells and podocytes (Rak-Raszewska et al., 2012a). Another 
study by Vigneau et al showed that Bra
+
 cells derived from mouse EBs 
contributed to the proximal tubules when injected into the neonatal mouse kidney 
in vivo (Vigneau et al., 2007). The results we obtained with the Bra-GFP
+
 cells 
obtained from cavitating EBs were surprising. We had expected that as these cells 
were isolated at a later time point than the Bra-GFP
+
 cells in the non-cavitating 
EBs, they might more closely resemble posterior mesoderm, which has recently 
been shown to generate the MM but not the UB (Taguchi et al., 2014). We 
therefore thought that these cells might integrate into developing nephrons, but 
not the UBs. However, they did not integrate into either of these structures and 
instead appeared to differentiate into endothelial cells. There have been 
contrasting reports concerning the presence of endothelial cells in mouse kidney 
rudiments cultured ex vivo, with some studies suggesting endothelial cells cannot 
 
    
 
136 
C
h
a
p
te
r 
1
 
C
h
a
p
te
r 
2
 
C
h
a
p
te
r 
3
 
C
h
a
p
te
r 
4
 
C
h
a
p
te
r 
5
 
C
h
a
p
te
r 
6
 
C
h
a
p
te
r 
7
 
C
h
a
p
te
r 
1
 
C
h
a
p
te
r 
2
 
C
h
a
p
te
r 
3
 
C
h
a
p
te
r 
4
 
C
h
a
p
te
r 
5
 
C
h
a
p
te
r 
6
 
C
h
a
p
te
r 
7
 
C
h
a
p
te
r 
1
 
C
h
a
p
te
r 
2
 
C
h
a
p
te
r 
3
 
C
h
a
p
te
r 
4
 
C
h
a
p
te
r 
5
 
C
h
a
p
te
r 
6
 
C
h
a
p
te
r 
7
 
C
h
a
p
te
r 
1
 
C
h
a
p
te
r 
2
 
C
h
a
p
te
r 
3
 
C
h
a
p
te
r 
4
 
C
h
a
p
te
r 
5
 
C
h
a
p
te
r 
6
 
C
h
a
p
te
r 
7
 
C
h
a
p
te
r 
1
 
C
h
a
p
te
r 
2
 
C
h
a
p
te
r 
3
 
C
h
a
p
te
r 
4
 
C
h
a
p
te
r 
5
 
C
h
a
p
te
r 
6
 
C
h
a
p
te
r 
7
 
C
h
a
p
te
r 
1
 
C
h
a
p
te
r 
2
 
C
h
a
p
te
r 
3
 
C
h
a
p
te
r 
4
 
C
h
a
p
te
r 
5
 
C
h
a
p
te
r 
6
 
C
h
a
p
te
r 
7
 
C
h
a
p
te
r 
1
 
C
h
a
p
te
r 
2
 
C
h
a
p
te
r 
3
 
C
h
a
p
te
r 
4
 
C
h
a
p
te
r 
5
 
C
h
a
p
te
r 
6
 
C
h
a
p
te
r 
7
 
C
h
a
p
te
r 
6
 
survive in ex vivo rudiments (Loughna et al., 1997) and others suggesting they do 
(Halt et al., 2016). Our findings are consistent with the Halt et al study that 
indicates endothelial cells are present in rudiments, and similarly to that study, we 
found that although the endothelial cells formed interconnected networks, they did 
not form capillaries with lumen, nor did they invest the developing glomeruli. 
 
The key differences in the gene expression profile of the Bra-GFP
+
 cells isolated 
from cavitating EBs (current study) and non-cavitating EBs (previous study) 
(Rak-Raszewska, 2010) is that in comparison to GFP
-
 cells, the former expressed 
much higher levels of Foxf1, which is identified in lateral plate mesoderm, and 
lower levels of the MM genes, Gdnf and Osr1 (Rak-Raszewska, 2010). The high 
expression levels of Foxf1 might explain why the EB-derived Bra-GFP
+
 cells in 
the current study had a tendency to generate endothelial cells, because it is known 
that Foxf1 is essential for vasculogenesis in the developing embryo and is 
expressed in endothelial cells (Ren et al., 2014; Mahlapuu et al., 2001).  
High level of BMP signals and their receptors ALK3/6 have been shown to 
promote a lateral plate mesoderm fate (James and Schultheiss, 2005). Due to the 
heterogeneous nature of the EBs, it is possible that mesoderm niches that 
resemble dynamic microenvironments of the in vivo primitive streak have been 
formed. Cells residing in the niches that are exposed to high concentrations of 
BMP signals might, therefore, adopt a lateral plate mesoderm fate. Retinoic acid, 
FGF and Wnt signals might also affect the cell commitment of lateral plate 
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mesoderm but their effects may be stochastic within the EBs. Nevertheless, we 
cannot exclude the possibility that the timing might have been another factor; for 
instance, Bra-GFP
+
 cells isolated at slightly earlier or later time-points might have 
expressed genes of other mesodermal lineages.  
 
Regarding the Bra-GFP
+
 isolated from the 2-D system, it was found that these 
also did not integrate into developing nephrons or UBs. Furthermore, only a small 
proportion of these cells appeared to differentiate into endothelial cells. The 
majority of the cells did not form interconnected cell networks and appeared to be 
randomly dispersed throughout the stroma. Similarly to the Bra-GFP
+
 cells from 
the cavitating EBs, the Bra-GFP
+
 cells from the 2-D system did not show any 
noticeable up-regulation of Gdnf or Osr1 in comparison with the Bra-GFP
-
 cells. 
However, in contrast to the EB-derived cells, those isolated from the 2-D system 
did not show up-regulation of Foxf1, which is consistent with their limited 
tendency to generate endothelial cells. It is possible that the Bra-GFP
+
 cells from 
the 2-D system might have differentiated into stromal cells, but it was not possible 
to test this due to the lack of a stroma-specific antibody. It is interesting to note 
that the Bra-GFP
+
 cells from the 2-D system expressed higher levels of the 
stromal gene, Foxd1 (Mugford et al., 2008) compared to those from the 3-D 
system, but the results were not statistically significant (chapter 5).  
 
 
The desirable goal for the Bra-GFP
+
 cells to incorporate into the kidney rudiments 
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is to generate functional kidney compartments for use as disease models and for 
kidney regeneration. However, in the current study, these cells did not appear to 
be committed to the nephrogenic fate. Nevertheless, they might be a useful tool 
for generating the vasculature and/or stromal compartments of the kidney which 
are essential for development and maturation of the kidney in vivo (Little, 2016). 
In addition, a combination of activin A, retinoic acid and BMP7 is able to induce 
mouse ESCs to generate renal epithelial cells that integrate into tubules (Kim and 
Dressler, 2005). It is thus possible that applying these molecules to the Bra-GFP
+
 
cells could promote their integration into the rudiments.  
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Chapter 7   
 
General Discussion and Conclusion 
                                                                   
 
The main aim of this work was to explore whether the mesoderm arising in the 
cavitating 3-D EBs is equivalent to the mesoderm that is generated in the 2-D 
monolayer culture system. In this project, we generated a Bra-GFP/Rosa26-E2C 
mESC reporter line by knocking an E2C transgene into the ubiquitously- 
expressed Rosa26 locus. We showed that the reporter cells retained the expression 
of stemness genes. We also showed that the reporter cells were able to generate 
typical cavitating EBs in vitro and could form teratomas in vivo, suggesting that 
the transgene insertion did not affect their pluripotency.  
 
An initial aim of the study was to track the fate of the E2C reporter cells within 
the internal organs of adult mice in vivo using fluorescence imaging. However, it 
was found that imaging the E2C reporter cells following subcutaneous injection 
was extremely difficult and required large numbers of cells. Therefore, it was 
concluded that in this context (i.e., following insertion of a single copy of the E2C 
cDNA into the Rosa26 locus), the E2C is not an effective reporter for in vivo 
imaging. No attempts were made to image the cells following systemic 
administration in living mice, as it was felt that this would be futile, and therefore, 
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the use of animals for such an experiment could not be justified. 
 
Although the E2C
+
 reporter cells are not suitable for imaging in vivo, it was 
possible to image them in vitro. The targeted E2C transgene in the Rosa26 locus 
appeared to be stable within the reporter cells during the culture period, implying 
that this approach would be suitable for tracking cells over the long-term. Indeed, 
the E2C signal could be detected in histological sections of teratomas generated 
by injecting the reporter subcutaneously into adult SCID mice. However, the 
signal intensity was weak and could only be detected using indirect 
immunofluorescence, using a primary antibody specific to E2C. In addition, 
despite the fact that we generated a line (clone +C4, Chapter 3) with a purity of 
99%, it was still notable that the E2C fluorescence intensity was not high. Data 
from flow cytometry analysis showed that the maximum E2C intensity was 
around 10
3
 (Figure 3.6). This might be due to low copy number (only a single 
copy) of the E2C in the Rosa26 allele of the knock-in line (Friedrich and Soriano, 
1991). Another possible explanation is the mild strength of the intrinsic Rosa26 
promoter. A comparison between the Rosa26 endogenous promoter and eight 
exogenous promoters including β-actin, human cytomegalovirus (CMV), mouse 
phosphoglycerate kinase (PGK) and CMV early enhancer/chicken β-actin 
promoter/rabbit β-globin intron composite promoter (CAG) in mESCs revealed 
that the activity of the endogenous Rosa26 promoter was similar to that of β-actin, 
which was 9- to 10- fold less than that of CAG (Chen et al., 2011). As the 
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transgene is placed in the first intron under the direct control of the Rosa26 
endogenous promoter, the lower activity of the native Rosa26 promoter may result 
in insufficient E2C expression levels that may not be easy to be detected in deep 
tissues. To circumvent this, one of the possible solutions could be to insert a 
transcription enhancer upstream to the transgene within the intron 1; for instance, 
the successfully used CAG enhancer (Niwa et al., 1991). An alternative option 
would be to use a luciferase bioluminescent reporter instead of a fluorescent 
reporter. For in vivo animal imaging, bioluminescence provides high sensitivity. 
(Close et al., 2010). However, although bioluminescence is more sensitive than 
fluorescence, spatial resolution is poor. Therefore, it would be necessary to 
confirm cell fate by undertaking immunostaining of histological sections using 
antibodies that detect luciferase.   
 
Flow cytometry analysis of Bra expression in mesoderm populations generated 
from 3-D and 2-D systems revealed that 2-D induction culture generated a high 
proportion of GFP
+ 
cells. In contrast, GFP
+
 expression within the EBs was not 
uniform and fewer GFP
+
 cells were present. Although the 2-D system appeared 
more efficient, the 3-D system remains as a useful tool to generate and isolate 
cells from EBs, the development of which shows striking similarities to the early 
embryo. It would therefore be expected that specific cell types isolated from EBs 
might more closely resemble their counterparts in the developing embryo than 
would the same cell types isolated from 2-D differentiation culture.  
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To characterise the two types of mesodermal cells, highly-pure mesoderm and 
non-mesoderm populations, namely Bra-GFP
+ 
and Bra-GFP
- 
cells, were isolated 
from 3-D EB and 2-D monolayer culture conditions and the expression profile of 
key genes was investigated using quantitative RT-PCR. The results showed that, 
between the Bra-GFP
+ 
cells isolated from the 3-D and 2-D systems, there was no 
significant difference in the relative expression levels of key mesodermal genes 
Bra and Tbx6, but the nascent mesoderm – lateral plate mesoderm gene Foxf1 was 
surprisingly up-regulated by 30-fold in the mesoderm cells isolated from 3-D 
system. This was a striking difference from our group’s previous observations of 
very low Foxf1 expression in the mesoderm cells of non-cavitating EBs 
(Rak-Raszewska, 2010). This could be because the mesoderm cells isolated from 
the cavitating EBs might already have specified into more differentiated 
mesodermal lineages, such as the lateral plate mesoderm. 
 
The mouse kidney rudiment assay showed that Bra-GFP
+
 cells isolated from the 
3-D system tended to become endothelial-like cells. This was not observed in our 
previous study using the non-cavitating EBs (Rak-Raszewska, 2010). Therefore, 
the immediate future work would be to repeat the assay with mesoderm cells 
isolated from the non-cavitating EBs derived from this E2C-labelled mESC 
reporter line to examine whether the previous results can be confirmed, as it 
cannot be ruled out that the different approaches used to track the fate of the cells 
(i.e., quantum dots in the previous study compared with the integration of the E2C 
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reporter gene in the present study), might have effected their behaviour. 
 
Direct reprogramming of kidney lineages provides an alternative approach to 
regulating mesodermal cell behaviour in vitro. Induced pluripotent stem cells 
(iPSCs) generated from human kidney mesangial and urine-derived renal tubular 
cells have been shown to have the potential to differentiate into renal podocytes 
(Li et al., 2016; Song et al., 2012; Zhou et al., 2011). Recent progress of directly 
reprogramming human adult proximal tubule cells to nephron progenitors by 
using six genes indicates the great potential of stem cells in kidney regeneration 
(Hendry et al., 2013). 
 
In conclusion, the mesoderm population isolated from the 3-D (i.e., EBs) system 
showed different characteristics compared to the mesoderm cells isolated from 
2-D mESC culture system in terms of key mesoderm gene expression profiles and 
differentiation potential. It is possible that, during mesoderm development, slight 
differences in the timing and/or exposure to regulatory signals lead to divergent 
differentiation paths. In the current rudiment study, this subtle deviation likely 
results in varied cell fates in vitro and ex vivo. 
 
Further work would be needed to monitor mESC differentiation in the 3-D and 
2-D cultures in more detail. A possible idea could be to generate dual-reporter 
mESC lines that enabled the expression of Bra and a marker of more 
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differentiated mesoderm to be monitored simultaneously in real-time during in 
vitro differentiation culture.  
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S1 
Appendix  
 
Table 1 Tumour Monitoring Record Post Injection of Bra-GFP/Rosa26-E2C mESCs 
Mouse 
No. 
Cell 
Lines 
Cell 
No. 
(Mil.) 
Day 4  Day 7  Day 9 
W 
(g) 
L 
(mm) 
W 
(mm) 
H 
(mm) 
 
W 
(g) 
L 
(mm) 
W 
(mm) 
H 
(mm) 
 
W 
(g) 
L 
(mm) 
W 
(mm) 
H 
(mm) 
  
1 E2C 10 19.34 5.1 6.2 2.0  19.15 N/A N/A N/A  19.52 N/A N/A N/A 
7.5 N/A N/A N/A N/A N/A N/A 6.4 4.5 3.5 
5 N/A N/A N/A N/A N/A N/A 4.4 4.4 2.2 
Ctrl 10 N/A N/A N/A 6.8 6.7 4.0 9.2 9.0 7.7 
2 E2C 10 17.00 3.4 4.4 2.0 17.55 3.6 3.5 3.0 17.72 5.6 4.7 3.2 
7.5 N/A N/A N/A 5.2 5.3 3.0 9.6 8.9 6.4 
5 N/A N/A N/A 4.0 4.9 3.0 9.0 6.8 4.7 
Ctrl 10 N/A N/A N/A 3.6 3.3 3.0 5.4 5.4 3.0 
3 E2C 10 18.20 5.8 6.0 2.0 20.45 8.5 5.2 3.0 20.88 9.9 9.7 5.3 
7.5 N/A N/A N/A 7.0 7.0 3.0 9.7 9.6 6.7 
5 N/A N/A N/A 3.0 3.0 1.0 4.8 3.4 1.0 
Ctrl 10 N/A N/A N/A  3.0 3.0 1.0  5.5 4.8 3.2 
 (W, weight; L, length; W, width; E2C, Bra-GFP/Rosa26-E2C mESCs; Ctrl, untransfected E14-Bra-GFP mESCs) 
 
 
 
S2 
Table 2 Tumour Volume and In Vivo Monitoring Record Post Injection of Bra-GFP/Rosa26-E2C mESCs 
Cell 
Lines 
Cell 
No. 
(×106) 
Mouse 
No. 
ROI values (e+08) (radiance: p/sec/cm2/sr) Volume (mm3) 
Day 0 Day 1 Day 4 Day 7 Day 9 
 
Day 4 Day 7 Day 9 
E2C 10 1 2.127 1.368 2.376 1.881 1.834 33.11 0.00 0.00 
2 2.142 1.305 2.275 2.276 2.480 15.67 19.79 44.10 
3 2.723 1.908 4.135 3.933 3.122 36.44 69.43 266.49 
Mean 2.331 
±0.340 
1.527 
±0.331 
2.929 
±1.046 
2.697 
±1.089 
2.479 
±0.644 
28.41 
±11.159 
29.74 
±35.768 
103.53 
±142.840 
7.5 1 2.657 1.780 2.981 3.129 3.109 0.00 0.00 52.78 
2 2.243 1.447 2.983 2.639 2.749 0.00 43.29 286.31 
3 1.742 1.174 2.330 2.860 2.416 0.00 76.97 326.68 
Mean 2.214 
±0.458 
1.467 
±0.303 
2.813 
±0.376 
2.876 
±0.245 
2.758 
±0.347 
0.00 
±0.000 
40.09 
±38.584 
221.92 
±147.866 
5 1 2.180 1.580 2.459 2.528 2.546 0.00 0.00 22.30 
2 1.821 1.318 2.869 2.017 2.127 0.00 30.79 150.61 
3 1.705 1.659 2.475 2.429 2.608 0.00 4.71 8.55 
Mean 1.902 
±0.248 
1.519 
±0.178 
2.601 
±0.232 
2.325 
±0.271 
2.427 
±0.262 
0.00 
±0.000 
11.83 
±16.583 
60.48 
±78.351 
Ctrl 10 1 1.419 1.115 1.849 1.459 1.475 0.00 95.42 333.83 
2 1.826 1.448 2.933 1.895 2.227 0.00 18.66 45.80 
3 2.122 1.357 3.517 2.361 2.861 0.00 4.71 44.23 
Mean 1.789 
±0.353 
1.307 
±0.172 
2.766 
±0.846 
1.905 
±0.451 
2.188 
±0.694 
0.00 
±0.000 
39.60 
±48.844 
141.29 
±166.744 
(ROI, region of interest; E2C, Bra-GFP/Rosa26-E2C mESCs; Ctrl, untransfected E14-Bra-GFP mESCs) 
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Video 1 Stitched growth video of Day 3–Day 7 EBs derived from Bra-GFP/Rosa26-E2C mESCs using the Cell-IQ imaging facility,  
        showing cavitating progress during the culture period. EBs were imaged on an hourly basis.   
 
 
 
 
